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the most common reason for hospitalization of Medicare recipients. HF is prevalent, costly to society and
complex to manage. The purpose of this body of work was to strengthen the evidence base for self-care
by studying understudied aspects of HF self-care maintenance.
Methods/Results: This body of work entails four discrete studies. The first study identified modifiable
predictors of patients who are at risk of consuming a diet higher in sodium than recommended by the
2010 Heart Failure Society of America guidelines. The second study identified two unique patterns of
sodium intake, "very high" (mean 4.5 g/day) and "generally adherent" (mean 2.4 g/day). Predictors of the
very high sodium intake group were being obese, having diabetes mellitus and less than 65 years old. The
third study identified unique patterns of inflammation and myocardial stress in a sample of patients with
HF from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)
clinical trial. Predictors of the worst biomarker pattern were identified and exercise was protective for
being in the worst biomarker pattern. In response to these studies, the Motivational Interviewing Tailored
Interventions for Heart Failure patients (MITI-HF) randomized controlled trial was designed and
conducted to test the efficacy of a tailored motivational interviewing approach to improve self-care,
physical HF symptoms and quality of life in patients with HF. Motivational interviewing was a successful
approach for improving self-care maintenance, but there were no differences between groups for selfcare management, self-care confidence, physical HF symptoms or quality of life.
Conclusions: In the context of the rising prevalence of HF within an environment of increasing costconscious appropriation of healthcare resources, this body of work provides evidence for targeting selfcare interventions to patients who are at highest risk of poor outcomes. It also provides evidence that
motivational interviewing is a successful approach for improving self-care maintenance behaviors,
specifically eating a lower sodium diet and exercising.
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ABSTRACT

PROFILING PATIENTS WITH HEART FAILURE AND TESTING A
MOTIVATIONAL INTERVIEWING INTERVENTION TO IMPROVE HEART
FAILURE SELF-CARE

Ruth M. Masterson Creber
Barbara J. Riegel

Background: Heart failure (HF) is the fastest growing cardiovascular syndrome in the
United States and the most common reason for hospitalization of Medicare recipients. HF
is prevalent, costly to society and complex to manage. The purpose of this body of work
was to strengthen the evidence base for self-care by studying understudied aspects of HF
self-care maintenance.
Methods/Results: This body of work entails four discrete studies. The first study
identified modifiable predictors of patients who are at risk of consuming a diet higher in
sodium than recommended by the 2010 Heart Failure Society of America guidelines. The
second study identified two unique patterns of sodium intake, “very high” (mean 4.5
g/day) and “generally adherent” (mean 2.4 g/day). Predictors of the very high sodium
intake group were being obese, having diabetes mellitus and less than 65 years old. The
third study identified unique patterns of inflammation and myocardial stress in a sample
vi

of patients with HF from the Heart Failure: A Controlled Trial Investigating Outcomes of
Exercise TraiNing (HF-ACTION) clinical trial. Predictors of the worst biomarker pattern
were identified and exercise was protective for being in the worst biomarker pattern. In
response to these studies, the Motivational Interviewing Tailored Interventions for Heart
Failure patients (MITI-HF) randomized controlled trial was designed and conducted to
test the efficacy of a tailored motivational interviewing approach to improve self-care,
physical HF symptoms and quality of life in patients with HF. Motivational interviewing
was a successful approach for improving self-care maintenance, but there were no
differences between groups for self-care management, self-care confidence, physical HF
symptoms or quality of life.
Conclusions: In the context of the rising prevalence of HF within an environment of
increasing cost-conscious appropriation of healthcare resources, this body of work
provides evidence for targeting self-care interventions to patients who are at highest risk
of poor outcomes. It also provides evidence that motivational interviewing is a successful
approach for improving self-care maintenance behaviors, specifically eating a lower
sodium diet and exercising.
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CHAPTER I: INTRODUCTION
Background and significance

Heart failure (HF) is a cardiovascular syndrome that affects more than 5.1 million
Americans over the age of 20.1 Currently, HF is the fastest growing cardiovascular
condition in the United States.2 Three primary risk factors of HF include age,
hypertension and coronary heart disease. Hypertension and coronary heart disease
currently affect approximately 77.9 and 15.4 million Americans over the age of 20
respectively.1 Forecasts project that by 2030, 41.4% of all US adults will have
hypertension.1 Increasing prevalence of coronary heart disease coincides with a decrease
in mortality of coronary heart disease, (annual death rate declined 40.3% and the actual
number of deaths declined 27.1% from 1999-2009).3 The decline in mortality from
coronary heart disease results in a greater population at risk of developing HF, due to the
fact that people are living longer with damaged myocardium. In addition, HF is a
common endpoint for other prevalent cardiovascular and extra-cardiovascular diseases
including: cardiac valve disorders, cardiomyopathy, diabetes mellitus, renal failure and
obesity.4-7 The combined impact of these factors results in a projected 46% increase in
HF prevalence from 2012 to 2030 resulting in more than 8 million people with HF.1
Managing a single complex medical condition such as HF was estimated to cost
$32 billion in the United States (U.S.) in 2012 and costs are estimated to increase 127%
to 69.7 billion between 2012 and 2030.2 A large proportion of treatment costs are
attributed to over one million annual hospitalizations in the U.S.,8,9 of which 90% are
1

potentially preventable.10 HF is the most common reason for the hospitalization of
Medicare recipients.9 In total, heart disease accounted for almost 2 million discharges in
2010 (among Medicare beneficiaries) with an average length of stay of 4.8 days and an
average cost of $11,132 per hospitalization at discharge.11 Thirty-day readmission rates
are reported to be as high as 27% 9 and more than one third are readmitted within 90
days.9,10 Overall, HF hospitalization rate declined from 1998-2008, but at a lower rate for
black men than for other demographic groups.1
One avenue for cost savings is to reduce unnecessary hospitalizations. The costs
incurred by Medicare for what may be preventable readmissions are estimated to be
about $17 billion or 20% of Medicare’s hospital payments.10 Due to this high cost
burden, the Centers for Medicare and Medicaid Services have taken a tough stance to
reduce HF readmissions. As part of the Affordable Care Act, the Hospital Readmission
Reduction Program has reduced payments to hospitals if patients with HF are admitted at
the same or a different hospital within 30-days of a previous hospital admission.12
Patients with HF frequently are readmitted to the hospital because they experience
exacerbations in their symptoms caused by cardiac dysfunction, generally left or right
ventricular hypertrophy, which cause neurohormonal and circulatory abnormalities, and
manifest as symptoms such as fluid retention, shortness of breath and fatigue on
exertion.13 HF is a complex syndrome to manage because clinical symptoms vary
considerably between patients and during the course of the disease. Depending on the
severity and degree of vigilance in management, recurrent bouts of acute exacerbations
are common. If patients survive an acute exacerbation they are at high risk of
2

rehospitalization.14,15 To reduce the economic and social burden of HF and improve
patient outcomes, better management strategies that incorporate optimized medical
therapy in concert with effective self-care are critical.14-17
Conceptual Model
The concept of “self-care” in HF refers to the practices in which patients engage
to maintain their own health and the decision-making process around managing signs or
symptoms.18-20 In recent work by Riegel and colleagues, they provide evidence that selfcare decisions are guided by a naturalistic decision making process.21 Naturalistic
decision making is defined as real-world decision making which takes into account
multiple competing factors, limited time, uncertainty, high stakes, vague goals, unstable
conditions and other unknowns.22 Self-care decision making is affected by situation
awareness with mental simulation of a plausible course of action and evaluation of that
outcome in addition to past experience, characteristics of the decision and personal
goals.21 The naturalistic decision making process is particularly relevant in the context of
HF because it is a chronic condition that requires constant decision-making around health
practices and symptom management in order to maintain hemodynamic stability.20 Selfcare is measured most commonly in research with two instruments, the European Heart
Failure Self-Care Behavior Scale23 and the Self-Care of Heart Failure Index.24
Self-care entails two core components, choosing positive health practices (‘selfcare maintenance’) and making decisions around the management of symptoms signs and
symptoms (‘self-care management’).18-20 The foundation of self-care is self-care
maintenance, as illustrated in The Situation Specific Theory of Heart Failure Self-care19
3

(Figure 1.1). Self-care management builds on routine self-care maintenance practices
starting with symptom monitoring and ending with critical decision-making and followup. As such, symptom monitoring is a bridge between self-care maintenance and
management. Recognizing symptoms is a necessary pre-cursor to being able to gauge
symptom importance, implement treatment and evaluate the response.
Figure 1.1: The Situation Specific Theory of Heart Failure Self Care

Self-care maintenance
Self-care maintenance involves performing positive health practices, such as
medication adherence, consuming a low-sodium diet, staying physically active,
monitoring daily weight and other symptoms, keeping medical appointments, avoiding
tobacco and limiting alcohol consumption.20 Arguably the most critical daily self-care
behavior is medication adherence—no other treatment is equally able to modify the
physiological cascade associated with HF.20 Two of the most understudied aspects of
self-care maintenance include eating a low sodium diet and doing routine exercise. In this
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body of work, a particular focus will be given to these two self-care maintenance
behaviors.

Low-sodium diet
Consuming a low sodium diet is one of the most frequently recommended selfcare behaviors; however, it is estimated that only 22-55% of HF patients adhere to a lowsodium diet.25-27 The rationale for moderate sodium restriction is that in general, sodium
promotes fluid retention, higher ventricular filling pressures and symptoms of congestion,
all of which put patients with HF at higher risk for acute decompensation and
hospitalization.25,28-31 The guidelines for HF are consistent in recommending a lowsodium diet,13,32-36 though they differ in terms of their specificity—from general
moderation32 to 2-3 g/day and further restriction for severe HF.13 All of the guidelines are
based on expert opinion, or level C evidence, not clinical trial data.
Exercise
Patients with HF are encouraged to exercise because physiologically, regular
exercise dilates coronary and peripheral skeletal vessels,37 stimulates angiogenesis,38 and
causes reductions in peripheral hypoxia,39 local inflammation,40 and resting heart rate.41
Results from smaller studies demonstrate that sustained exercise therapy improved
myocardial contractility, diastolic filling, myocardial perfusion, and endothelial
dysfunction.37,39,42-45 Despite this wide range of benefits, few patients with HF regularly
engage in exercise.46,47 One of the reasons why few patients with HF routinely exercise is
5

that safety of exercise was not established until the results of the Heart Failure: A
Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) trial were
reported in 2008. Previously, health providers did not routinely recommend exercise.
The purpose of HF-ACTION was to determine whether aerobic exercise could
reduce all-cause mortality, all-cause hospitalization and improve quality of life. HFACTION included 2,331 patients who were randomized to an exercise or control group
for 30 months.48,49 Though there was no difference between the two study groups in allcause mortality or all-cause hospitalizations in the primary analysis, there was a
difference in health status between the exercise training and control groups.50 The study
reported in Chapter IV is based on a sub-sample of data from HF-ACTION.
Self-care management
Self-care management is a more complex process than self-care maintenance
because it requires critical decision-making and follow-up action. Four steps to the selfcare management process have been specified. The first step entails recognizing early
signs and symptoms. Though the recognition of symptoms may seem straightforward, it
is not easy for many patients with HF to detect changes in their symptoms—including
even large increases in body weight due to fluid retention.51 Many patients with HF have
other co-morbid conditions so symptoms such as breathlessness or fatigue are often
attributed to asthma, chronic obstructive pulmonary disease, lack of physical activity,
over-exertion or aging.52 If symptoms are not routinely monitored and recorded then
recognizing subtle changes that occur over time can be difficult. The second self-care
management step entails deciding that a change in symptoms requires a response,
6

followed by taking action. Finally, patients need to be able to evaluate whether their
response to the symptom was effective.20

Factors affecting self-care
There are multiple social, psychological, and physical factors that affect a
patient’s ability to perform and maintain HF self-care. For instance, social support from
family members, especially spouses, children and close friends, is instrumental in
influencing adherence to prescribed medications.20,53-55 Depression is also associated with
delays in seeking medical care56 and is one of the main psychological factors that affect
self-care in HF.54 Depression is highly prevalent among both inpatients (50%) and
outpatients (11-25%) with HF.57 People who are depressed are less likely to engage in
health practices such as smoking cessation or regular exercise.58 Physically, general
cognitive impairment is estimated to affect 25% of patients with HF, including
impairment of executive function, memory, language, mental speed and attention.59,60
Physiologically, cognitive impairment in HF can be caused by impaired cerebral vessel
reactivity, microembolisms61 and chronic hypoperfusion.61,62As such, cognitive
impairment adversely affects self-care.61,63,64 In addition, age and HF severity are
associated with reduced cerebral blood flow due to abnormalities in the heart-brain
vascular loop.62 HF is also associated with white-matter infarcts and reduced gray-matter
volume,65 both of which impact memory, psychomotor speed and executive function,66
which are critical for adequate self-care. Knowledge of how people with cognitive
impairment perform self-care is limited by the fact that they are excluded from many
7

studies, due to ethical issues around informed consent, problems with follow-up, dropout
and adherence to a protocol. Social support, depression and cognitive impairment are just
three factors among many that influence a patient’s ability to maintain HF self-care.

Self-care and Clinical Outcomes
Self-care is considered an evidence-based recommendation for preventing health
outcomes (ie: hospitalizations) and improving patient-oriented outcomes (ie: quality of
life). Systematic literature reviews by McAlister and colleagues and Jovicic and
colleagues report a decrease in HF hospitalization and all-cause re-hospitalization among
patients who engage in self-care.67,68 A major limitation of this early work is that selfcare was not actually measured; it was assumed to be the mechanism by which event-risk
was reduced. In the Heart Failure Adherence and Retention Trial (HART) trial (n=902),
self-management counseling plus HF education was compared with HF education alone
for the primary end point of death or HF hospitalization.69 There was no difference in the
primary outcome between the two groups, suggesting that self-management counseling
did not reduce death or HF hospitalization in patients with mild to moderate HF.70 Most
recently, Dracup and colleagues reported the results of the Rural Education to Improve
Outcomes in HF clinical trial. Once again, there were no differences in the clinical
outcomes of hospitalization and cardiac death between patients randomized to the
education intervention and control groups.71 The association between self-care and
patient-reported measures of health status and quality of life is also unclear, primarily due
to conceptual and methodological weaknesses in self-care intervention studies.72,73 In a
8

review of 21 interventions on the benefits of self-care on quality of life, some
demonstrated improved quality of life in response to self-care interventions and others
reported no effect.72 A positive association between HF self-care and health status was
found when both self-care management and self-care confidence were high.74 While it is
believed that self-care improves both clinical and patient-oriented outcomes, more
research is needed to determine what dose and type of self-care interventions are needed
to improve these outcomes. Evidence of improvement in health outcomes could impress
patients with HF and clinicians of the critical role that self-care can have on both duration
and quality of life.
The relationship between self-care behaviors and specific biomarkers of
inflammation and neurohormonal activation has been reported in a cross-sectional study
of 168 symptomatic patients with HF.75 A one-point increase in the self-care management
scale of the Self Care of HF Index was associated with a 12.7% reduction in levels of Nterminal pro-B-type natriuretic peptide and soluble tumor necrosis factor receptor type 1,
which are associated with higher risk of hospitalization and death.75 Lee and colleagues
have proposed that oxidative stress may be reduced through better volume homeostasis,
which decreases mechanical stress and ventricular wall stretch.20,75 That is, being attuned
to early symptoms of congestion and responding promptly with effective self-care
management techniques may promote fluid volume homeostasis.75-77
In a review article on HF self-care, Riegel and colleagues support the
development of personalized, or tailored, interventions to address barriers, improve selfefficacy and focus on key self-care maintenance and management skills.20 In the context
9

of complex long-term conditions like HF, the rationale for using a tailored approach is
that it may motivate individual patients and increase the likelihood that they will actively
implement self-care maintenance or management behaviors.78 Tailoring is a form of
individualization or personalization, which attempts to increase motivation by developing
a customized plan that addresses relevant preferences and needs. Tailored approaches to
cardiovascular disease prevention may involve the assessment of genetic variants,
biomarkers and imaging modalities,2 as well as specific interventions and educational
materials. Bennett and colleagues implemented tailored educational content to personal
health beliefs and behaviors and found it improved self-care in patients with HF.79
Tailored interventions are designed to take into consideration specific characteristics and
desired outcomes of individuals using a combination of strategies and information based
on individual assessment.80 Theoretically, tailoring may enhance the impact of a health
message by altering attention and influencing how a message is processed by enhancing
cognitive preconditions for effortful processing.81 Whether a tailored intervention will
provide superior improvement in self-care and quality of life is addressed in this body of
work.
Purpose and specific aims
The primary purpose of this body of work was to strengthen the evidence base for
self-care by studying specific HF self-care maintenance behaviors. The secondary
purpose was to test the efficacy of a tailored motivational interviewing (MI) approach to
improve self-care, quality of life, physical HF symptoms and clinical outcomes.

10

The first aim was to identify patterns and predictors of high sodium intake. The
hypothesis was that interventions that promote a low-sodium diet should be targeted to
patients with HF who are most likely to consume high quantities of sodium. To address
the first aim, two quantitative analyses were performed. As reported in Chapter II,
predictors of higher than recommended sodium intake were identified using a mixed
effect logistic analysis from a longitudinal dataset of 280 patients with HF. Secondly, as
reported in Chapter III, two distinct patterns of sodium intake were identified using an
alternative growth mixture modeling analysis. Conceptually, both of these studies address
the self-care maintenance skill of maintaining a low-sodium diet.
Table 1.1 Aim 1: Patterns and predictors of high sodium intake
Aim

1) Identify predictors of high sodium intake.
Hypothesis: Identifying predictors of high sodium
intake informs who should be targeted with lowsodium diet interventions.

Title of paper for how aim was
addressed
Chapter II: Identifying predictors of
higher than recommended sodium intake
in HF patients using a mixed effect
logistic analysis of longitudinal data
Chapter III: Using growth mixture
modeling to identify subgroups of
sodium adherence in adults with HF

2) Identify distinct biomarker patterns and
identify predictors of the worst biomarker pattern.

Hypothesis: Common and distinct patterns of
biomarkers of inflammation and myocardial stress
can be identified. Predictors of these patterns can
also be identified and subsequently used to target
high-risk patients.
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Chapter IV: Identifying biomarker
patterns and predictors of inflammation
and myocardial stress

3) Design and implement Motivational
Interviewing Tailored Intervention (MITI-HF) to
improve HF self-care.

Chapter V: Motivational interviewing
tailored interventions for heart failure
(MITI-HF): design and methods

Hypothesis: Participants in the motivational
interviewing group will have higher self-care
outcome scores, quality of life and physical
symptoms burden compared to the usual care
group.

Chapter VI: Motivational interviewing
tailored interventions for heart failure
(MITI-HF): self-care, physical HF
symptoms and quality of life

The second aim was to identify common and distinct patterns of change in serum
biomarkers of inflammation and myocardial stress and quantify the influence of exercise
therapy on patterns of change in a community-based sample of patients with HF.
Currently, little is known about which a priori factors predict biologic patterns
characterized by inflammation and myocardial stress in patients with HF. As reported in
Chapter III, three distinct patterns of inflammation and myocardial stress were identified
and predictors of the worst biomarker pattern are reported. Conceptually, this study
supports the self-care maintenance behavior of exercise as a mechanism for slowing the
progression of HF.
The third aim, reported in Chapters V and VI, was to test the efficacy of MI to
improve self-care behaviors, physical HF symptoms and quality of life in patients
recently discharged from a HF hospitalization. Differences between the study groups
were tested and reported for statistical and clinical improvement from baseline to 90-days
in self-care maintenance, self-care management, self-care confidence, physical HF
symptoms and quality of life. This study supports using a tailored motivational
interviewing approach to improve heart failure self-care maintenance.
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Summary
This dissertation explores multiple bio-behavioral methods for profiling patients
with HF who are most vulnerable to poor self-care, physiologic and clinical outcomes.
This work specifically addresses characteristics of patients who are at higher risk of
consuming a high-sodium diet and predictors of worse patterns of inflammation and
myocardial stress, both of which can be used to target interventions to the most
vulnerable patients with HF. This work also tests whether a tailored motivational
interviewing intervention is able to improve self-care behaviors, physical HF symptoms
and quality of life and in a pilot randomized controlled trial. Finally, this body of work
concludes with overall themes and recommendations for future research and clinical
practice.
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Abstract
Background: A low-sodium diet is a core component of heart failure self-care, but
patients have difficulty following the diet.
Aim: The aim of this study was to identify predictors of higher than recommended
sodium excretion among patients with heart failure.
Methods: The World Health Organization Five Dimensions of Adherence model was
used to guide analysis of existing data collected from a prospective, longitudinal study of
280 community-dwelling adults with previously or currently symptomatic heart failure.
Sodium excretion was measured objectively using 24-hour urine sodium measured at
three time points over six months. A mixed effect logistic model identified predictors of
higher than recommended sodium excretion.
Results: The adjusted odds of higher sodium excretion were 2.90, (95% confidence
interval (CI): 1.15-4.25, p<0.001) for patients who were obese; 2.80 (95% CI: 1.33-5.89,
p=0.007) for patients with diabetes; and 2.22 (95% CI: 1.09-4.53, p=0.028) for patients
who were cognitively intact.
Conclusion: Three factors were associated with excess sodium excretion, and two,
obesity and diabetes, are modifiable by changing dietary food patterns.
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Introduction
Heart failure is a major public health concern because it is associated with high
morbidity, mortality and cost. Self-care is recognized as a means of improving these
outcomes.1 Consuming a low-sodium diet is one of the most frequently recommended
self-care behaviors; 2-5 however, it is estimated that only 22-55% of patients with heart
failure are adherent to a low-sodium diet.6-8 The rationale for not consuming excessive
sodium is that it can lead to fluid retention, higher ventricular filling pressures and
symptoms of congestion9—all of which put patients with heart failure at risk for acute
decompensation and hospitalization.10, 11
The general recommendation for all adults in the United States is to consume less
than 2,300 milligrams (mg) of sodium a day; however, the average American consumes
approximately 3,400 mg of sodium per day.12 Sodium is one of the primary cations in
extracellular fluid. By influencing the shifting of water between body compartments, it
plays an important role in maintaining body fluid tonicity,13 blood volume and pressure.
The Heart Failure Society of America (HFSA) guidelines recommend that patients with
symptoms of heart failure restrict daily sodium intake to 2,000-3,000 mg/day. 6 The most
recent 2013 American Heart Association (AHA) Guideline for the Management of Heart
Failure recommends sodium restriction (< 3000 mg/day) for patients with stage C and D
heart failure.14
Patients with heart failure face a number of barriers to effectively quantifying
sodium intake and maintaining a low-sodium diet. A major barrier is that many patients
do not find low sodium foods palatable and consequently never adjust to the taste of low
23

sodium foods and change their eating habits.15 A lack of knowledge about how to identify
high sodium foods, even when labeled, is also a barrier for patients.15-18 Few restaurants
offer low-sodium options, which decreases dining out opportunities for socialization with
friends.15-17 Overall, there are multiple barriers that can impede patients with heart failure
from consistently following a low-sodium diet.
The aim of this study was to identify socio-demographic and clinical
characteristics that predict higher than HFSA recommended sodium intake, estimated by
urinary sodium excretion, using longitudinal data of patients with heart failure. For the
purposes of this study, we assumed that sodium excretion was a reflection of sodium
consumption. The World Health Organization (WHO) Five Dimensions of Adherence
model was used to identify factors potentially associated with poor dietary adherence.19
This holistic model acknowledges the multi-dimensionality of adherence including social
and economic conditions, the health care system, as well as condition-, therapy- and
patient-related factors.19 Previously, this model has been used to guide the assessment of
medication adherence in patients with heart failure.20
Methods
Study population
This study was a secondary analysis of data collected in an observational
prospective cohort study of 280 community-dwelling adults with previously or currently
symptomatic heart failure who were followed over a six-month time period. This study
was in compliance with the Declaration of Helsinki.21 Institutional Review Board
approval was obtained from all three sites and all participants gave written informed
24

consent. The parent study was conducted to investigate the relationship between
excessive daytime sleepiness and heart failure self-care. The detailed methodology of this
study has been reported elsewhere. 22 In brief, this was a prospective cohort study with
patients assigned to one of four cohorts based on excessive daytime sleepiness and
cognitive decline. Multiple heart failure self-care behaviors were measured including
eating a low sodium diet, which was assessed with 24-hour urine sodium specimens at
three time-points (enrollment, 3- and 6-months). Patients with heart failure were
prospectively enrolled from three outpatient settings, two in Pennsylvania and one in
Delaware, between 2007 and 2010. The basic eligibility criteria for participation
included: (1) chronic heart failure with prior or current symptoms, (2) ability to read and
speak English, and (3) sufficiently able to complete questionnaires and study procedures
(i.e. adequate cognition, English fluency, ability to read). Patients were ineligible to
participate in the study if they had dementia, as measured by the Telephone Interview for
Cognitive Status23 along with other criteria specified in the parent study. 22 Most
participants in this study were followed in specialty heart failure clinics and were on
standard medical therapy. The usual care provided by heart failure specialty clinics was
not augmented in this observational study.
Variables and Measures
Clinical information (e.g., etiology and type of heart failure, left ventricular
ejection fraction (LVEF), and comorbid illnesses) was abstracted from the medical record
by a registered nurse at each of the three enrollment sites. These nurses were familiar
with the unique electronic medical record systems in their own setting. Each nurse
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received extensive training to assure consistency of data collection. The principal
investigator assured the fidelity of the data collection protocol at each site and was
available for questions throughout the study period.
Comorbidities (including diabetes) were scored with the Charlson Comorbidity
Index, a commonly used measure,24 directly from the medical record. In this sample, all
patients had a score of at least one because they all had heart failure. Validity was
demonstrated by the instrument authors when comorbidity scores (categorized as low,
medium, and high) predicted risk of ten-year mortality, complications, health care
resource use, length-of-hospital-stay, discharge disposition and cost.24-27
New York Heart Association (NYHA) functional class was scored Class I-IV by a
single board certified cardiologist using data obtained from a standardized interview.28
Body mass index (BMI) was calculated based on patients weight at the baseline visit and
self-reported height. Detailed information on participants’ medications, with doses, was
collected at each data collection period. Sociodemographic characteristics were selfreported.
Cognition was measured with a battery of neuropsychological tests administered
in person by trained research assistants. The number of tests on which participants scored
below their age-based norm was used as an indicator of cognitive status. Any participant
who scored more than 1.5 standard deviations beyond the range of normal on at least two
of the paper-and-pencil tests was considered to have mild cognitive decline. For analysis,
the cognition variable was dichotomized to indicate those with or without cognitive
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impairment. The details of the neurocognitive battery and methodology for categorizing
cognitive status are reported in detail in the parent study.22
In this study, dietary sodium intake was approximated using urine sodium
excretion. Sodium is under tight homeostatic control and is only lost from the body as
sweat (20-80 mmol/day), stool (5-10 mmol/day) or urine (1-500 mmol/day).29 Patients
with heart failure do not typically engage in strenuous physical activity; therefore do not
lose sodium from heavy perspiration. Variations in sodium excretion are primarily due to
variations in recent sodium intake.30 In this study, we made the assumption that the 24hour urinary sodium excretion samples reflected dietary sodium intake across the study
period, consistent with previous studies.10, 31, 32 The 24-hour urine collection method has
been validated by urine recovery of oral doses of para-amino benzoic acid 33-35 and the
collection procedures followed in the parent study were consistent with recommendations
for collection by the Institute of Medicine.36
Based on criteria set forth by the 2010 HFSA practice guidelines and published
papers, urine sodium in mmoles was converted to mg (mg= mmole*22.99).5, 10 The urine
sodium binary outcome in this study was created using 3,000 mg/day 24-hour urine
sodium cut point for patients in NYHA Class I/II and a 2,000 mg/day 24-hour cut point
for patients in NYHA Class III/IV. Expected dietary sodium categories were compared
between participants whose dietary sodium excretion was within recommended levels
versus those in higher than recommended levels.
Procedures

27

Data were collected at baseline, three, and six months by research assistants
during home visits. Training for urine specimen collection was provided for the patient
and family member, if available, at the baseline data collection interval. Prior to each
subsequent urine collection, patients were telephoned to remind them and reinforce
training for the procedure. Patients were given urine containers, collection devices, verbal
and written instructions (with pictures) specifying when they should start and finish
collecting the urine specimen. Participants were instructed to start the collection at 0800,
discard that specimen, and collect the final specimen at 0800 on the following day. Prior
to the patient collecting each urine specimen, the research assistant inquired about
changes in the medication regimen. If the participant had experienced a recent medication
change the collection was delayed for three days starting from the date the medication
was changed. Participants recorded when their urine sodium collection started and
finished. A courier picked up the specimens from the participant’s homes after the 24hour sample was completed.
The central laboratory at the Hospital of the University of Pennsylvania analyzed
the urine samples to determine the amount of sodium in each specimen using the ionselective electrode method (Beckman LX® 20 Chemistry Analyzer, Beckman Coulter,
Inc., Fullerton, CA).
Statistical Analysis
Descriptive statistics were used to calculate frequencies with percentages and
means with standard deviations for the total sample, urine sodium in grams per day, and
sodium consumption. Chi-square and Kruskal-Wallis tests were used to compare baseline
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characteristics of binary, categorical and ordinal variables between groups. For the
purposes of between group comparisons, the doses for patients on loop diuretics (n =183)
were converted to furosemide equivalents using the following formula: furosemide 80 mg
= torsemide 40 mg = bumetanide 2 mg.37 The other participants on diuretics (n = 8) were
prescribed hydrochlorothiazide and compared separately. This method has been used in
other studies.10
Over the three points of data collection, data on the urine sodium excretion were
missing overall in 23% of the participants (193/840 samples), 19% at baseline, 29% at 3months and 23% at 6-months. Multiple imputations were performed for urinary sodium
excretion and body mass index (BMI) data to account for missing time-varying
covariates.38-40 Multiple imputation is a principled, likelihood based method using
statistical modeling to impute data using the method of chained equations.41 In short, this
method creates ten copies of the data, as recommended by Rubin.40 The multiple
imputations were based on baseline age, gender, etiology of heart failure, cognitive status
and LVEF and complete data for time-varying covariates, including NYHA class, BMI
and urine sodium excretion. Each dataset was then analyzed separately. 42 Estimates of
the parameters of interest were averaged across all the datasets to give a single, final
estimate. 42, 43 After imputation, data were checked to confirm reasonable values.
Standard errors and 95% confidence intervals were estimated by calculating within and
between components of variance using the method of Rubin.40
To determine predictors of higher than recommended sodium intake, a mixed
effect logistic model with a random intercept was tested for each patient. Adjusted odds
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ratios, 95% confidence intervals and p-values are presented for statistically significant
predictors of higher than recommended sodium intake fit on the imputed data.44 The
selection of model covariates was based on four of the five dimensions of adherence from
the WHO conceptual model: condition, therapy, patient-related factors and social and
economic conditions as well as statistical association with the outcome variable, urine
sodium excretion. The final twelve covariates included in the multivariable regression
models are presented in Table 2.1.45
Table 2.1: World Health Organization five dimensions of adherence model
Dimension of adherence
Social/economic factors
Therapy-related factors
Patient-related factors
Condition-related factors
Health-system factors

Variables used in this study
race, income, highest level of education
diuretic (loop or thiazide)
gender, age, body mass index, cognitive status
heart failure type (diastolic or systolic), diabetes,
hypertension, etiology (ischemic or non-ischemic)
Not available in this study

Two sensitivity analyses were conducted. First, mixed effect logistic estimates
were compared between the complete case and imputed data models. Estimates based on
imputed data were more conservative in terms of effect sizes and had narrower
confidence intervals. This was expected because confidence intervals and model variance
depend on the amount of missing data, sample size and number of imputed datasets.41, 46
Second, estimates from the mixed effects logistic models were confirmed with
generalized estimating equations models with robust standard errors. Data are not shown
for these two sensitivity analyses because there were no significant differences between
the models. All data analyses were performed using Stata v. 11.2.47
Results
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This sample of patients with heart failure had a mean age of 62 years (standard
deviation (SD): 12), was predominantly male (64%), functionally compromised (77% in
NYHA class III or IV) with a mean left ventricular ejection fraction of 35 (SD: 17). Over
one-third of the sample had diabetes. Among participants with diabetes 60% were also
obese. Over two thirds of the sample had hypertension, and about 20% had chronic
obstructive pulmonary disease. Sample demographic and clinical characteristics are
shown in Table 2.2. The urine sodium levels were relatively normally distributed so
mean and standard errors are presented. The majority of the sample was prescribed
furosemide or an equivalent loop diuretic.
Table 2.2 Demographic, social and clinical characteristics of patients and 24hour urine sodium urine samples: overall and by higher and lower sodium
excretion levels at baseline (N=280)
Variables

Age
<65 years
>=65 years
Gender
Male
Female
Race
Black/Other
White
Income
More than needed
Enough for needs
Less than needed
NYHA functional class
Class I+II
Class III
Class IV
Diuretic use*
Furosemide equ.
(mg/day) n=183
<= 40 mg/day

Total %

Mean UrNa
grams/day
(SE)

Na+ guidelines
Within or
Higher

p-value

165
115

41
59

3.08 (0.03)
2.61 (0.03)

48
52

63
37

0.022

180
100

64
36

3.23 (0.24)
2.81 (0.03)

61
39

66
34

0.425

105
175

38
62

2.95 (0.02)
3.30 (0.04)

33
67

37
63

0.597

98
137
45

35
49
16

2.75 (0.03)
3.21 (0.03)
3.35 (0.05)

38
51
11

33
48
19

0.269

66
164
50

23
59
18

3.03 (0.04)
3.02 (0.03)
3.28 (0.06)

33
49
18

17
68
15

0.009

3.07 (0.15)

72

69

0.703

183
91

50

2.97 (0.14)
31

>40 and <=120
mg/day
>120 mg/day
Hydrochlorothiazide
(mg/day)
HF etiology (n=279) †
Ischemic HF
Non-ischemic HF
BMI (n=279) †
Normal (18-24)
Overweight (25-29)
Obese (30+)
Highest level of
education
Less than high
school
High school
graduate
More than high
school
Type of heart failure
Systolic
Diastolic or mixed
Charlson Co-morbidity
Low
Moderate
High
Diabetes
Yes
No
Hypertension
Yes
No
COPD
Yes
No
Cognition
Cognitively impaired
Not cognitively
impaired

63

34

3.33 (0.27)

29
8

16
3

3.01 (0.27)
3.30 (0.53)

1

3

0.400

102
177

36
64

3.11 (0.03)
3.05 (0.03)

35
66

38
61

0.625

74
73
133

26
26
48

2.39 (0.03)
2.86 (0.05)
3.53 (0.02)

38
27
35

18
27
55

0.001

27

10

2.65 (0.07)

11

7

0.271

102

36

3.05 (0.03)

39

35

151

54

3.12 (0.03)

50

58

194
86

69
31

3.00 (0.02)
3.19 (0.05)

76
24

69
31

0.475

149
101
30

53
36
11

2.96 (0.04)
3.13 (0.06)
3.26 (0.09)

56
37
7

50
35
15

0.268

107
173

38
62

3.57 (0.05)
2.72 (0.04)

23
77

47
53

0.001

181
99

65
35

3.06 (0.02)
3.07 (0.03)

65
35

63
37

0.729

222
58

79
21

2.53 (0.06)
3.20 (0.03)

73
27

81
19

0.129
0.004

107
165

39
61

2.90 (0.02)
3.14 (0.03)

47
53

28
72

*Diuretic use: This only includes information on patients who were on diuretic medications. The
proportions are only for those prescribed furosemide (n=183), not the entire population sample. †Sample
size for variables with missing values. Abbreviations: SE=standard error, Na+=sodium, UrNa=urine
sodium, NYHA=New York Heart Association, COPD=chronic obstructive pulmonary disorder
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The median and interquartile range values for urine sodium excretion on the
complete cases at all three time points were 2,770 mg (1,750 – 3,950 mg) at baseline,
2,630 mg (1,690 – 4,000 mg) at 3-months and 2,780 mg (1,900 – 3,790 mg) at 12months. There was no trend in sodium excretion across time that would suggest that
participants modified their diets in anticipation of these measurements. We found no
difference in the pattern of observed values for participants with missing data and those
with complete observations.
Table 2.3 Factors associated with higher sodium excretion (n=280)
Variables

Adjusted OR

Cognition
Cognitively impaired
1.00
Cognitively intact
2.22
Body mass index
Normal (18-24)
1.00
Overweight (25-29)
1.79
Obese (30+)
2.90
Diabetes
No
1.00
Yes
2.80
Gender
Female
1.00
Male
1.16
Age
>=65 years
1.00
<65 years
1.95
Hypertension
0.51
Income
1.11
Diuretic use
1.05
Heart failure etiology
0.72
Type of heart failure
1.24
Education
1.14
Race
1.17
Abbreviations: OR: odds ratio, CI: confidence interval

95% CI

p-value

Reference
1.09 4.53

__
0.028

Reference
0.75 4.25
1.15 4.25

__
0.187
<0.001

Reference
1.33 5.89

__
0.007

Reference
0.54 2.51

__
0.703

Reference
0.97 3.90
0.25 1.04
0.67 1.84
0.48 2.33
0.31 1.67
0.78 1.98
0.67 1.96
0.57 2.42

__
0.059
0.068
0.696
0.897
0.438
0.351
0.607
0.663

In the final model identifying patient characteristics associated with higher than
recommended sodium intake (Table 2.3), patients with heart failure who were obese
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(BMI>30) had nearly three times higher adjusted odds of consuming more than
recommended sodium intake compared to patients with a normal body weight (BMI<25).
The adjusted odds of sodium intake above recommended level were over two times
higher in patients who were cognitively intact compared to patients with some cognitive
impairment. Patients with heart failure and diabetes had almost three times the adjusted
odds of consuming more than the recommended sodium intake.
Discussion
The purpose of the study was to identify characteristics of patients with heart
failure who had higher than recommended 24-hour urine sodium excretion. In this study,
we used 24-hour sodium excretion as an estimate of dietary sodium intake, or adherence
to sodium guidelines. Considering possible predictors drawn from the WHO adherence
model, the three most important predictors of higher sodium excretion were patient- and
condition-related factors. Patients with heart failure who were obese or had diabetes and
those who were cognitively intact were more likely to excrete higher amounts of sodium.
The association between higher sodium and obesity is most likely explained by
both direct and indirect effects.32, 48 One explanation for the relationship between obesity
and higher sodium consumption is that high-calorie foods often contain high sodium.49
Increased dietary sodium intake is directly correlated with increased calorie
consumption.31, 50 According to the Salted Food Addictive Hypothesis, salted foods act in
the brain like an opiate agonist, producing a hedonistic reward, which becomes associated
with foods being judged as “delicious” or “flavorful.” 48 Withdrawal of salty foods acts
like an opiate receptor withdrawal and causes perceived “cravings” for salted foods.48
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Over time, daily consumption of salted foods can produce an addiction, which escalates
and can stimulate overeating.51
The association between high sodium intake and obesity has also been found in
rat animal models52 and has a physiological explanation: chronic salt overload induces
adipocyte hypertrophy, which enhances insulin sensitivity for glucose uptake and insulininduced glucose metabolism.52 Song and colleagues report a direct effect between sodium
intake and risk of being overweight in humans, after adjusting for energy, water and soda
consumption;32 however their study sample did not include patients with heart failure,
hypertension or diabetes. The relationship between obesity and sodium consumption is
consistent with results of our previous study in which we found that patients with heart
failure who were overweight had a four-fold increased odds of consuming more than
3,000 mg of sodium per day.53
Other lifestyle factors may help explain the relationship between obesity and
sodium consumption. Processed and packaged foods are naturally high in sodium because
sodium is a natural preservative that increases the shelf life of foods. Patients with heart
failure often feel fatigued and may have less energy to dedicate to the purchase and
preparation of low-sodium food. Originally, we thought that purchasing fresh produce
and meat may be prohibitively expensive for patients on fixed or limited incomes;
however, income was not a statistically significant predictor of higher sodium excretion.
Another important question is whether the guidelines should recommend varying
amounts of sodium intake for people with heart failure with different body weight and
other clinical characteristics. According to Gupta and colleagues (2012) there is still
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uncertainty as to whether dietary sodium intake recommendations should be
individualized. 9
Diabetes was a strong predictor of higher than recommended sodium intake. This
may be explained by the fact that any form of kidney disease in which tubular
reabsorption of filtered sodium does not match the filtered load plus dietary intake can
cause renal sodium wasting (ie: hyperfiltration occurring in earlier stages of diabetic
nephropathy).13 The finding that diabetes is a predictor of higher sodium intake is
consistent with a previous analysis in which patients with diabetes were four times as
likely to consume more than 4 grams of sodium per day over time.53 This finding may be
explained by the association between diabetes and obesity, in which case diabetes is
acting as a marker of obesity.
In the literature, associations between mild cognitive impairment and heart failure
self-care behaviors are mixed.1, 54, 55 Mild cognitive impairment has been associated with
worse self-care management 56, 57 probably because of an inability to perform the
complex decision-making required to manage signs and symptoms. An association
between cognitive impairment and poorer self-care maintenance such as eating a low
sodium diet has not been reported. In a study by Cameron and colleagues, the majority of
patients (73%) had unrecognized or sub-clinical cognitive impairment and were as likely
to engage in health promoting behaviors, such as daily weighing, as those without
cognitive impairment.57 Dickson and colleagues reported that poorer cognition was
associated with better self-care behaviors among patients with heart failure in a mixedmethods study.58 It is important to note that these prior studies focused on the subjective
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assessment of multiple self-care behaviors and not exclusively on dietary sodium.
Further, there were considerable differences across studies in the methods of measuring
cognition that may, in part, explain differences in study findings.58
While it may be assumed that patients with mild cognitive impairment will not be
able to follow a low-sodium diet that was not the case in this study. Patients who were
cognitively intact had more than double the odds of consuming higher than recommended
sodium levels compared to patients with cognitive impairment. This seemingly counterintuitive finding may be explained by the fact that patients with cognitive impairment
often have caregivers who make and provide their meals. Patients who are cognitively
intact may be more self-reliant in making dietary decisions. This finding could also be
explained by the rigidity that is associated with cognitive impairment.59, 60 Rigidity refers
to the tendency to form and repeat particular behaviors; eating the same foods is one form
of rigidity. We cannot confirm either of these hypotheses because we did not collect data
on caregivers or rigidity associated with specific dietary choices in this study.
Many patients with heart failure struggle to consume levels of sodium that are
considered moderate. In a study of adults with heart failure from the Southern United
States, only 33% of individuals consumed 2000 mg/day or less with the wide range of
522 to 9251 mg/day.61 Likewise, based on 24-hour urinary sodium excretion levels,
another study reported that 34% of the sample was compliant with recommendations to
consume less than 3000 mg/day and only 15% consumed less than 2000 mg/day.10
Recently sodium restriction for patients with heart failure has been questioned due
to wide variation in the study protocols, study samples, fluid intake, measurement of
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sodium intake and compliance.14 Some studies have even questioned any sodium
restriction;62, 63 however, this was largely due to a very rigid definition of sodium intake
(80 mmol/day).62 Paterna and colleagues recommend a normal sodium diet, defined as
120 mmol/day (about 2800 mg/day) 62, 63 which is consistent with the recommendation of
< 3g a day for patients with Class C and D HF.14 Overall, the message across these
studies and a recent review by Gupta and colleagues is consistent— high sodium intake is
not optimal for patients with heart failure because excessive sodium intake is associated
with fluid retention; however, the lower-dose range of sodium intake needs to be better
defined, and possibly individualized to patients in future studies.9
Strengths and Limitations
One of the strengths of this study was the repeated measures of sodium excretion
on the same individuals over a six-month period. Multivariate statistical methods were
used for these repeated measures to account for the correlation of measures within an
individual, which reduced measurement error and individual variability. The use of
longitudinal data in this study also provided a clearer picture of how well patients
followed a low-sodium diet over an extended period of time, instead of one point in time.
Another strength of the study is that we used robust and transparent imputation methods
to address potential bias from incomplete data.38, 40
The study also had several limitations including the fact that this was a secondary
analysis of a dataset that did not include measures of sodium intake. Data from carefully
controlled studies show that at least 7 days of direct measurement of sodium intake and
excretion in the urine are needed to achieve correlations of 0.8,64 which implies that food
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records and urine excretion provide complementary information about sodium intake.
The relationship between sodium intake and excretion is analogous to fasting blood
glucose and hemoglobin A1c in diabetic patients. These two measures provide similar,
but different, information about dietary adherence in patients with diabetes. In this study,
our intention was not to precisely estimate sodium intake over the previous 24 hrs, but to
estimate general adherence to dietary recommendations. For our purposes, 24-hour
sodium excretion was the best available marker of dietary sodium consumption.
Another limitation of this study was that patients in this sample were on loop
diuretics, which enhance urinary excretion of sodium by inhibiting tubular reabsorption at
the thick ascending limb of the Loop of Henle, in the nephron.13 Arcand and colleagues
(2010), found no statistically significant relationship between 24-hour urine sodium
excretion and sodium intake from food records in patients with heart failure on a loop
diuretic; however, they reported significant correlations for non-heart failure cardiac
patients and for patients with heart failure who were not prescribed a loop diuretic.65
While informative, limitations of the Arcand study were that it used a cross-sectional,
correlational design in a young, relatively small sample of patients with heart failure in
which other relevant variables that may explain the differences in sodium excretion were
not controlled. Though there may be some imprecision from using urinary sodium
excretion as a measure of dietary sodium intake for patients on loop diuretics, it is still
considered the best measure for patients with heart failure.10, 31, 66 In addition, we
statistically controlled for diuretic use.
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There are inherent limitations to a secondary data analysis, including the fact that
this study was limited by the demographics and size of the original sample. For example
this sample was younger than most other community dwelling samples of patients with
heart failure so the results may not be generalizable to older adults with heart failure.
There may be additional predictors of higher sodium intake that were not measured in the
parent study, such as fluid intake, and thus could not be controlled for. In addition, while
it was a strength that we used four of the five dimensions of adherence in the WHO
model, the dimensions were not measured comprehensively. For instance, due to the
sample size, we were restricted to including only variables that were both conceptually
consistent with the WHO dimension as well as statistically associated with sodium
excretion in the final model. Some dimensions may not have been fully captured by the
variables selected.
Conclusion
Patients with heart failure who are cognitively intact, those who have diabetes or
are obese are at risk for consuming more sodium than recommended. The 2013 Report of
the AHA Guideline for the Management of Heart Failure recommends reasonable sodium
restriction for patients with symptomatic HF to reduce congestive symptoms14 and the
HFSA guidelines recommend that all patients with heart failure be provided with dietary
instruction.5 Sodium dietary instructions should be contextualized within a longer
conversation with patients about their general sodium intake. Further research may
support identifying higher risk patients and intervening to help them decrease their
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sodium intake. Ultimately, interventions around dietary sodium intake may help decrease
their risk of decompensation and re-hospitalization.11, 67
Implications for Practice
•

Patients who have diabetes, are obese or are cognitively intact might be at risk for
consuming more sodium than recommended.

•

Further research should identify patients and intervene to help them reduce high
sodium consumption with tailored dietary interventions.
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Abstract
Background: The prevention of fluid retention is important to reduce hospitalizations in
patients with heart failure. Following a low-sodium diet helps to reduce fluid retention.
Objective: The primary objective of this study was to use growth mixture modeling to
identify distinct classes of sodium adherence—characterized by shared growth
trajectories of objectively measured dietary sodium. The secondary objective was to
identify patient-level determinants of the nonadherent trajectory.
Methods: This was a secondary analysis of data collected from a prospective longitudinal
study of 279 community-dwelling adults with previously or currently symptomatic heart
failure. Growth mixture modeling was used to identify distinct trajectories of change in
24-hour urinary sodium excretion measured at three time points over six months. Logistic
modeling was used to predict membership in observed trajectories.
Results: The sample was predominantly male (64%), mean age 62 years, functionally
compromised (59% NYHA class III), with non-ischemic HF etiology. Two distinct
trajectories of sodium intake were identified and labeled adherent (66%) and nonadherent (34%) to low-sodium diet recommendations. Three predictors of the nonadherent trajectory were identified, confirming our prior mixed-effect analysis.
Compared with normal weight patients (BMI <25), being overweight and obese was
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associated with a 4-fold incremental increase in the likelihood of being in the nonadherent trajectory (odds ratio (OR): 4.63, 95% confidence interval (CI): 1.66-12.91,
p<0.002). Being less than 65 years of age (OR: 4.66, 95% CI: 1.04-20.81, p=0.044) or
having diabetes (OR: 4.15, 95% CI: 1.29-13.40, p=0.016) were both associated with over
four times the odds of being in the non-adherent urine sodium trajectory compared with
people who were over 65 or without diabetes, respectively.
Conclusions: Two distinct trajectories of sodium intake were identified in patients with
heart failure. The non-adherent trajectory was characterized by an elevated pattern of
dietary sodium intake shown by others to be associated with adverse outcomes in heart
failure. Predictors of the non-adherent trajectory included higher body mass index,
younger age and diabetes.
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Introduction
Adherence to a low-sodium diet is an important self-care behavior for patients
with heart failure (HF). Excess sodium intake promotes higher ventricular filling
pressures, pulmonary congestion, clinical symptoms of fluid retention, and puts patients
with HF at high risk for acute decompensation and hospitalizations. 1 As such, adherence
to a low-sodium diet is a key factor in reducing hospitalizations2 and one of the most
frequently recommended self-care behaviors. 3-6 Both the 2012 European Society of
Cardiology and 2009 American College of Cardiology/American Heart Association
guidelines recommend less than 2 g/day of dietary sodium. 7,8 Likewise, the Heart Failure
Society of America recommends that all patients with clinical symptoms of HF restrict
sodium to 2-3 g/day. 6 It is estimated, however, that only about 22-55% of HF patients
are adherent to a low-sodium diet. 9-12
Adherence, as defined by the World Health Organization (WHO), is a
multidimensional phenomenon, determined by multiple dimensions related to social and
economic conditions, the health care system in addition to condition, therapy or patientrelated factors.13 Like medication adherence in this patient population, adherence to a low
sodium diet is influenced by a number of factors.14 Although several factors have been
associated with non-adherence to a low-sodium diet in the adult population with HF,
there are limitations to these research findings. Most prior studies on 24-hour urine
sodium excretion are cross-sectional in design and conducted with small samples.
Deterministic methods, including mixed effects modeling have previously been used to
identify patient-level factors associated with high sodium intake using an a priori
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determined cutoff of adherence.15 This study builds on that analysis by applying a growth
mixture modeling methodology to identify the “most likely” trajectory membership and
quantify uncertainty in trajectory membership over time.
The specific aim of this study was to use growth mixture modeling to identify
distinct patterns of change in 24-hour urine sodium excretion, as a proxy for dietary
sodium intake, over six months of observation. The secondary aim was to build on a
previous mixed effects analysis15 and examine patient-level determinants of observed
trajectories of urine sodium.
Methods
Design and Study population
The methodology of this study has been previously reported in detail. 14 In brief,
this was a prospective, observational study of the association between excessive daytime
sleepiness and HF self-care among 279 community-dwelling adults with chronic HF. The
participants were enrolled from three outpatient settings in Philadelphia, Pennsylvania
and Newark, Delaware between 2007 and 2010. Most of the participants were followed
in specialty HF clinics and most were on optimal medical therapy. Given the
observational nature of this study, the usual care provided by HF specialty clinics was not
augmented. Participants did not receive supplemental HF self-care education outside of
what was provided as part of routine care.
Inclusion criteria for the study specified adults with previously or currently
symptomatic HF confirmed by echocardiographic and clinical evidence. 14 The
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participants needed to be able to actively participate in the study, so inclusion criteria
specified that patients must be able to read and speak English and have sufficient
cognition and health literacy to complete the questionnaires. Otherwise eligible
individuals were excluded if they lived in a long-term care setting and were not
responsible for their own self-care, including preparing and making choices about food.
People were also excluded if they had renal failure requiring dialysis, imminent plans to
move out of the area, a history of drug or alcohol abuse within the past year or an
imminently terminal illness. People with major depressive illness were also excluded
because self-care behaviors are influenced by major depression. 16 This study was in
compliance with the Declaration of Helsinki. 17 Institutional Review Board approval was
obtained from all three sites and all participants gave written informed consent. Data
were collected at baseline, 3-and 6-months by research assistants during home visits.
Institutional Review Board approval was obtained for this secondary analysis.
Measurement of dietary sodium
A 24-hour urine sodium collection is considered a reliable and valid estimate of
sodium intake 18,19 and has been used as an objective measure of sodium intake in other
studies with patients with HF. 1,20 Sodium is under tight homeostatic control. If
individuals do not perspire heavily, urine sodium accounts for approximately 95% to
98% of daily dietary sodium intake. 21 Variations in 24-hour urine sodium are primarily
attributed to changes in sodium intake over the previous 24 hours.22 Daily urine sodium
levels are estimated to fluctuate only about 11%. 23 Validation for 24-hour urine
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collection has been performed by urine recovery of oral doses of para-amino benzoic
acid.19,23,24
The methodology for collecting and measuring dietary sodium intake has been
reported elsewhere 15 and is summarized here. Dietary sodium intake was estimated using
three 24-hour urine sodium levels measured at enrollment, and at three and six months
after enrollment. The procedure for the collection and quantification of the 24-hour urine
samples is summarized here. At the time of enrollment, participants and their family
members were given training for the specimen collection. Participants were provided
with all necessary supplies including: urine containers, collection devices, verbal and
written instructions (with pictures) specifying when they should start and finish collecting
the specimen. Prior to each urine collection, patients were given a reminder call and
training for the procedure was reinforced by the research assistant. Participants selfreported the start and stop time of the urine collection. If the recorded time was less than
22 hours or greater than 26 hours it was considered inaccurate and excluded from the
analysis. Specimens were collected from participant’s homes by a courier service shortly
after the 24-hour sample was complete.15
Urine sodium analyses were completed at the central laboratory at the Hospital of
the University of Pennsylvania using the ion-selective electrode method (Beckman LX®
20 Chemistry Analyzer, Beckman Coulter, Inc., Fullerton, CA) to determine the amount
of sodium in the urine specimens. A normal urinary sodium level is 40 to 120
mEq/L/day. 11 In order to compare urine excretion with the recommended diet of 2-3
g/day sodium intake, 6 urine sodium excretion in millimoles was converted to g (g=
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mmol* .02299) to estimate dietary sodium intake. As a quality assurance measure,
urinary creatinine was measured concurrently. Normal urinary creatinine is 1 ± 10% g 25
so any samples with creatinine levels <0.9 g in 24 hours were considered incomplete.26
Statistical Analysis
Standard descriptive (proportions, means and standard deviations), unadjusted
odds ratios and t tests were used to describe the sample and compare trajectories. Latent
growth mixture modeling was used to identify distinct trajectories of urinary sodium
using data from three time points.
Latent class growth modeling is used to examine patterns in longitudinal data with
repeated measures to identify classes or subgroups within a population. Unique
trajectories or pathways differentiate classes from one another. Using repeated measures
to identify subgroups within a population has been used across multiple disciplines.
Latent class growth mixture analysis also has been used across multiple disciplines to
identify trajectories of development; 27 nighttime continence;28 physical aggression in
young boys;29 the natural history of prostate disease;30 depression recovery profiles31 and
preventative interventions for reducing classroom violence. 32 It has also been used
extensively in the substance abuse literature to identify trajectories and predictors of
high-risk behavior.33-44 Within the heart failure literature, it has been used to identify
patterns of cognitive change,45 as well as patterns of medication nonadherence. 46
The purpose of growth mixture modeling is to identify homogenous subgroups
within larger heterogeneous populations and represent unobserved heterogeneity among
subjects in a sample. Finite mixture random effects are used to represent the departure of
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individuals’ latent growth parameters from the population mean growth parameter. 32,47
Class membership of an individual cannot be measured directly; however, it can be
inferred based on membership in a specific trajectory.48 According to Wang and
colleagues growth mixture modeling can be described as having three steps. The first step
is analogous to random effects modeling which specifies individual-level observed data
as a sum of fixed effects, random effects and measurement errors at each observation
point. 48 The second step represents the distribution of class-specific random effects and
covariate effects on class-specific mean growth trajectories. The third step includes the
covariate effects on class membership using regression models. 48
Growth mixture modeling has many benefits over alternative methods, as
reviewed by Preacher.49 Growth mixture modeling can model changes in factors over
time as random effects, allow for variations between individuals and subgroups (instead
of individuals and the population average as in mixed-effect modeling) and judge
comparative fit between iterative models with various statistics; the focus of growth
mixture modeling is on capturing inter-and-intra-individual differences over time.50
Conventional deterministic approaches minimize within group and maximize betweengroup variance. In contrast, growth mixture modeling employs a model-based approach
to calculate the probability of membership in each trajectory, identify “most likely”
trajectory membership, and quantifies uncertainty in trajectory membership. In this
article the terms subgroups and classes are used synonymously to describe people who
share a specific growth trajectory.
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Growth mixture modeling was performed using MPlus v.6.12 (Los Angeles, CA).
Model fit between 2 to 4 trajectories were compared (k vs k-1 trajectories) using the LoMendell-Rubin adjusted likelihood ratio test (p<0.05), parametric bootstrapped likelihood
ratio test (p<0.05), Bayesian Information Criteria (BIC), convergence (entropy closest to
1.0), the proportion of the sample in each trajectory (not less than 5%), and average
posterior probabilities (closest 1.0). 50,51 Predictors of observed trajectories of dietary
sodium were quantified using logistic regression modeling in MPlus. Unadjusted and
multivariate odds ratios (OR) and 95% confidence intervals (CI) were calculated for each
model factor, taking into account our method of multiple imputation, described below.
The following ten determinants of non-adherence were tested based on the five
dimensions of adherence posed by the WHO.52 Four of the five WHO adherence
dimensions were included in this analysis. The fifth factor was not included because data
on the health care system was not available for this secondary data analysis. Patient
related factors included gender, age and BMI. Social and economic factors included race,
income and highest level of education. Condition related factors included New York
Heart Association (NYHA) functional class, HF type (diastolic or systolic), etiology of
HF and diabetes as a comorbidity. Therapy related included diuretic use.
Robust Handling of Missing Data
In an effort to reduce bias, a principled method of multiple imputation53 was
performed to account for missing urine sodium excretion values (23% of the sample had
at least one missing value). Data were imputed using the method of chained equations
(Stata v. 11.2). 54-56 The method of chained equations is a contemporary technique that
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imputes missing data based on multiple covariates in the dataset (i.e. a full information
method of imputation). The latent class variable was fit on imputed data in Mplus v.6.12.
Multiple sensitivity analyses were performed to examine potential differences in the
significance and effect size of predictors of urine sodium trajectories comparing complete
case with imputed data samples. There were no differences in the predictors identified in
the models except for the size of the confidence intervals; thus, for economy of
presentation, only the final analysis using imputed data is shown here.
Results
The overall demographic and clinical characteristics of the sample population
overall at baseline are presented in Table 3.1. This sample of adults (n=279) with HF was
predominantly male (64%), had a mean age of 62, non-ischemic HF etiology and was
functionally compromised (59% NYHA class III). The unadjusted odds ratios for the
analysis are presented in Table 3.2. The covariates that had a statistically significant
unadjusted association with the non-adherent trajectory were diabetes (p=0.008), income
(p=0.031) and BMI (p<0.001).
Modeling of three and four trajectories resulted in poor model fit and small
trajectories (data not shown). Entropy for the two-class model was 0.752 and there were
high average posterior probabilities of membership in both trajectories (94% and 91%),
indicating very limited uncertainty in trajectory membership. Based on the observed
characteristics, we labeled the first and largest trajectory “adherent” (n=178, 66%) and
second trajectory “non-adherent” (n=91, 34%).
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Table 3.1: Characteristics of the overall sample at baseline (n=279)
Overall n (%)
Age
< 65 years
>=65 years
Gender
Male
Female
Race
Black/Other
White
Income
More than needed
Enough to meet needs
Less than needed
NYHA functional class
Class I+II
Class III
Class IV
Heart failure etiology
Ischemic HF
Non-ischemic HF
Hypertension
Yes
No

165 (59)
114 (41)
179 (64)
100 (36)
104 (38)
175 (63)
98 (35)
137 (49)
44 (16)
65 (23)
164 (59)
50 (18)
102 (37)
177 (63)
180 (65)
99 (35)

Overall n (%)
Diuretic
Yes
No
Cognitive Impairment* (n=271)
Yes
No
Heart failure type
Diastolic/Mixed
Systolic
Body mass index * (n=278)
Normal
Overweight
Obese
Highest level of education
Less than high school
High school graduate
More than high school
Diabetes
Yes
No
COPD
Yes
No

NYHA = New York Heart Association, COPD = Chronic obstructive pulmonary disease
*Variables containing missing data
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225 (81)
54 (19)
107 (40)
164 (61)
86 (31)
193 (69)
74 (26)
73 (26)
131 (47)
27 (10)
102 (37)
150 (54)
171 (61)
108 (39)
58 (21)
221 (79)

Table 3.2: Unadjusted odds of membership in the non-adherent urine
sodium trajectory (n=279)
Unadjusted
Odds Ratio
Gender
Female
Male
Body Mass Index
Normal
Overweight
Age
>=65 years
< 65 years
Diabetes
No
Yes
Race
White
Black/Other
Income
NYHA Functional Class
Heart failure etiology
Heart failure type
Diuretic
Cognitive Impairment *n=271
LVEF *n=278

95% CI

p-value

1.51

(reference)
0.57-4.03

>0.2

5.27

(reference)
2.23-13.06

<0.001

4.80

(reference)
0.45-51.80

0.20

3.71

(reference)
1.41-9.80

0.008

2.60
2.07
1.27
1.57
2.68
3.58
1.00
0.99

(reference)
0.97-7.00
1.07-4.02
0.69-2.37
0.37-6.68
0.89-8.03
0.35-36.62
0.44-2.27
0.97- 1.00

0.059
0.031
>0.20
>0.20
0.078
>0.20
>0.20
0.089

CI = confidence intervals, NYHA = New York Heart Association, LVEF = Left Ventricular Ejection
Fraction, *Variables containing missing data

As displayed in the Figure 3.1 there was heterogeneity within each trajectory, as
demonstrated by the error bars, which indicate two standard deviations around each mean
urine sodium level at each point in time. Paired t-tests demonstrate statistically significant
differences between the two trajectories at each time point (p<0.001). Those in the
adherent group started off at baseline with a mean sodium consumption of 2.42 g/day
(standard deviation (SD) ±0.19, 95% CI: 2.39-2.45) versus 4.41 g/day (SD: ±0.34, 95%
CI: 4.33-4.48) in the non-adherent trajectory (t=61.68, p<0.001). At three months, the
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mean difference between the two trajectories was 2.16 g/day (SE: 0.36, t=59.99,
p<0.001) and by six months was 1.98 g/day (SE: ±0.03, t=62.56, p<0.001). Within the
adherent and non-adherent trajectories there were no differences from baseline to 6
months (SE: ±0.02, t= -1.39, p=0.166 and SE: ±0.05, t= -0.47, p=0.640), indicating that
there were limited changes in dietary sodium intake over time.
Figure 3.1: Trajectories of adherence to a low-sodium diet

Based on the WHO model, predictors of membership in the non-adherence
trajectory were identified. The conceptual model was also supported using data driven
statistical approaches including univariate associations. Compared with normal weight
patients (BMI <25), being overweight and obese was associated with a 4-fold incremental
increase in the likelihood of being in the non-adherent trajectory (OR: 4.63, 95% CI:
1.66-12.91, p<0.002). Being less than 65 years of age (OR: 4.66, 95% CI: 1.04-20.81,
p=0.044) or having diabetes (OR: 4.15, 95% CI: 1.29-13.40, p=0.016) were both
associated with over four times the odds of being in the non-adherent urine sodium
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trajectory compared with people who are over 65 or do not have diabetes, respectively.
There were no significant differences in the odds of being in the non-adherent trajectory
based on gender, cognition, diuretic use, income level, education, race, HF etiology, HF
type or NYHA functional status.
Discussion
The primary aim of this study was to identify trajectories of sodium adherence in
a sample of community dwelling HF patients and two groups were identified. Based on
the more liberal Heart Failure Society of America sodium recommendations of 3g/day
sodium intake, 6 one trajectory was labeled “adherent” and the other “non-adherent” to a
low sodium diet. Both groups were consistently adherent or non-adherent over six
months of follow-up. That is, there was no change in the level of adherence or nonadherence over time.
To the best of our knowledge, this is the first study that describes adherence to a
low-sodium diet using a growth mixture approach; however, this method has been
applied to medication adherence in this study sample. 46 The predictors of the nonadherence to a low sodium diet were being overweight or obese, age less than 65 years
and having diabetes. These results that obesity and diabetes predict higher sodium
consumption are consistent with an analysis that employed a mixed-effect analytic
approach;15 however, in this study we also identified younger age as a risk factor for
being non-adherent to a sodium restricted diet.
HF patients who were overweight or obese, age less than 65 years or have
diabetes were identified as being more likely to have trouble following a restricted
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sodium diet and may need more focused, tailored self-care interventions.57 One approach
to tailoring self-care interventions that we are testing in a pilot randomized control study
is a tailored motivational interviewing and skill-building approach to improving self-care
behaviors including adherence to a low-sodium diet.
The finding that being obese is strongly associated with greater odds of being
non-adherent to a restricted sodium diet implies that these patients may be consuming
more food and by default more sodium, or that they are specifically consuming more
foods that are higher in sodium. This finding is consistent with the Intersalt international
study of electrolyte excretion and blood pressure, in which investigators reported a
positive correlation between BMI and sodium excretion.19 They proposed that overweight
individuals consuming higher sodium intake most likely explains this finding. 58 In
contrast, Chung et al 20 found no differences in BMI between people who self-reported
being adherent or non-adherent to low-sodium guidelines. The approach in our study is
different than that used by Chung and colleagues in that we did not apply a 2,000 mg
cutoff for sodium adherence. Instead, we identified distinct and naturally occurring
trajectories of urinary sodium excretion that happened to track with current dietary
sodium recommendations. Moreover, the current study was longitudinal in design. Thus,
methodological differences may explain our incongruent findings.
Other authors studying sodium adherence in the HF population have not reported
our finding of an association between younger age and non-adherence to a low sodium
diet. In studies of adherence to self-maintenance behaviors, an association between age
and adherence to medication has been reported. Several studies report that younger
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patients are more adherent to taking medication 59,60 while others found no consistent
difference in medication adherence by age. 61-63 In this specific sample, we found no
difference in overall medication adherence by age. 64 The association with younger age
and the non-adherent trajectory could be that younger patients with HF may also be more
newly diagnosed and not yet adept in the skills of identifying and avoiding hidden
sodium in foods. Patients with HF who are over 65 years may be living that long because
they have been more stringent with the self-maintenance behavior of eating a low salt
diet.
The finding that diabetes is a strong predictor of the non-adherence to a low
sodium diet is most likely explained by overconsumption of sodium, rather than a
physiologic mechanism. In fact, in the diabetic state of hyperinsulinemia, sodium
reabsorption is enhanced in the nephron segments of the kidney. 65-68 Clinically, patients
with both HF and diabetes may struggle to closely monitor both their sugar and their
sodium intake. There may receive conflicting messages from multiple providers about
nutritional priorities. The implications of this finding may be that interventions are
needed to specifically address the dietary complexities of managing both HF and diabetes
in this patient population.
Several factors that we anticipated would predict sodium adherence did not reach
statistical significance, including higher income and education. We expected that people
who reported having inadequate income would potentially be more likely to be nonadherent to a low sodium diet because low-sodium food is more expensive and time
consuming to prepare than processed, higher-sodium foods; however, there were no
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differences between people who reported more income than needed, enough to meet
needs or less than needed. Several investigators have suggested that people with more
years of education would be more adherent with medication; 62,69 however, education has
not been found to be associated with sodium adherence. In this study, we found no
differences in sodium adherence based on education. The lack of association between
years of education and adherence to low-sodium diet is consistent with the propositions
of the WHO adherence model,13 which suggests that higher education in and of itself
does not necessarily lead to higher health literacy or behavior change. In this specific
study, poor health literacy was an exclusion criterion. As an observational study, there
was also no intervention tested, limiting our ability to comment on behavior change.
There are probably many other barriers to following a low-sodium diet that are
more important than knowledge. For instance, an identified barrier for patients is the
perception that foods will taste bland and unappealing without added salt.57 This barrier
has been addressed by clinicians who promote flavoring with salt substitutes, using lowsodium cook books and allowing taste buds to adapt to lower-sodium foods.70 Other
contextual barriers identified in a qualitative descriptive study of older women with
hypertension and HF include eating alone with no motivation to cook healthy meals.
These women also identified that healthcare providers need to provide more education on
a low-sodium diet, as well as large-print informational materials.71 A study by De BritoAshurt (2011) identified barriers to dietary sodium restriction in people of Bangladeshi
origin with chronic renal disease living the UK.72 Though the disease and patient
population are different from this study population, the barriers, including deeply rooted
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dietary beliefs, attitudes and culturally established taste for salt,72-74 are likely to be
universal across patient populations.
Other authors found low-sodium diet adherence rates to be about 28% or 29%.
11,12

The findings from this study offer a different perspective from that of population-

average adherence. What we can say is that 66% of the sample fit the adherent profile to
sodium recommendations and 34% fit the non-adherent profile. These numbers cannot be
compared with other population averages or direct calculations of sodium adherence.
This non-deterministic approach offers advantages to understanding how non-adherence
can be examined and provides a list of useful predictors that are relevant to clinicians for
tailoring self-care interventions and education.
Strengths and Limitations
The primary strength of this study is the use of growth mixture modeling, which
enables moving away from quantifying the overall population average to examining and
quantifying heterogeneity and identifying distinct subgroups. Another strength of this
research is that it includes longitudinal data collected at three time points, on a relatively
large group of community dwelling stable patients with HF. Many other studies that have
examined sodium adherence included only one, 24-hour urine collection in small sample
sizes. With an even larger sample size, we may have been able to identify more latent
categories of adherence and more predictors of trajectory membership. Further research is
needed to determine if the two classes identified in this study will hold across multiple
populations of patients with HF. In other words, are these predictors consistent and
generalizable to different populations of patients with HF, or localized findings? The
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primary limitation of this dataset was that originally 23% of the total sample had missing
outcome data; however, this was accounted for, at least in part, by contemporary and
robust imputation techniques.

Conclusion
Two distinct trajectories of sodium intake were identified. The non-adherent
trajectory identifies a distinct pattern of dietary sodium intake that is not consistent with
current sodium guidelines. Identified predictors (overweight or obese, less than 65, or
having diabetes) can be used by clinicians to target interventions to patients who are most
likely to struggle with eating a lower sodium diet. Results can also be used to tailor
interventions and patient education programs to the highest risk groups. They can also be
incorporated into HF management programs. Future studies identifying the specific
barriers within these patient populations are also warranted so that the specific barriers
can be targeted with interventions.
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Abstract
Background: Regular exercise is recommended to improve physical function in patients
with heart failure (HF). Exercise is known to decrease inflammation and thought to
decrease myocardial stress. Studies of N-terminal pro b-type natriuretic (NT-proBNP)
and high-sensitivity C-reactive protein (hsCRP) have been mixed in patients with HF. A
multi-marker analysis may help identify distinct subgroups of HF patients who respond to
exercise. The primary study objective was to identify common and distinct patterns of
change in serum biomarkers of hsCRP and NT-proBNP and quantify the influence of
exercise therapy on the patterns of change.
Methods and Results: NT-proBNP and hsCRP were assessed in a random sample of
320 participants from the biomarker sub-study of the HF-ACTION study, a randomized
clinical trial of exercise training versus usual care in patients with stable and chronic HF.
Growth mixture modeling was used to identify unique biomarker patterns measured over
12-months. Three statistically independent and clinically meaningful biomarker patterns
of NTproBNP and hsCRP were identified. The largest “lowest and improving,” pattern
(61%) had the lowest levels of NT-proBNP and hsCRP at baseline, with declines over
time. The second “elevated and stable” pattern (34%) had higher hs-CRP and consistent
NT-proBNP over time. The smallest and most deleterious “elevated and worsening”
pattern (5%) had the highest levels of NT-proBNP and increasing hsCRP (p<0.001) over
time. Participants randomized to the exercise intervention were much less likely to have
the elevated/worsening pattern of NT-proBNP and hsCRP (relative risk ratio: 0.23, CI:
0.06-0.92, p=0.037).
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Conclusions: Exercise therapy was protective for reducing the frequency of membership
in the worst pattern, indicating that exercise may help slow the progression of HF.
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Introduction
Exercise therapy is considered a safe non-pharmacological intervention to
improve functional capacity1 and clinical outcomes2 for adults with heart failure.
Moderate exercise routines (3 to 7 metabolic equivalent hours per week) are associated
with a decreased risk of clinical events.3 Physiologically in patients with heart failure,
exercise training improves myocardial contractility, perfusion, endothelial dysfunction,4,5
angiogenesis,6 and coronary and peripheral skeletal vessel dilation.7 A challenge to the
broad implementation of exercise training in heart failure is physiologic heterogeneity in
response to exercise. That is, some patients respond to exercise therapy with reductions in
peripheral hypoxia,8 local inflammation9 and resting heart rate,10 while others do not.
Accordingly, the primary aim of this study was to identify common and distinct patterns
of change in serum biomarkers of systemic inflammation and myocardial stress among
adults with stable heart failure who participated in an exercise trial. The secondary aim of
this study was to identify socio-demographic and clinical predictors of the most
unfavorable patterns of change in biomarkers of systemic inflammation and myocardial
stress. We hypothesized that exercise therapy would be associated with more favorable
patterns of change in biomarkers over time.
Methods
Study population
This was a secondary data analysis of a random selection of 320 participants from
the complete cases of the biomarker sub-study of Heart Failure: A Controlled Trial
Investigating Outcomes of Exercise Training (HF-ACTION) randomized control trial.
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The full study design has been published previously.2,11 Briefly, HF-ACTION was a
multicenter, randomized control trial designed to examine long-term safety and efficacy
of aerobic exercise training in a large sample of medically stable, chronic outpatients with
heart failure. Enrollment criteria included reduced left ventricular ejection fraction
(LVEF) of 35% or less, New York Heart Association (NYHA) class II to IV and
willingness to undergo exercise training. Patients were excluded if they could not
exercise, were already habitual exercisers or had a cardiovascular event in the preceding
6 weeks. Participants were randomized from 82 centers within the United States, Canada
and France from 2003-2007 to a usual care or aerobic exercise-training group. The
intervention entailed 36 supervised sessions followed by home-based training.
All participants were to perform a maximal exercise test with gas exchange
measurements on a treadmill, using the modified Naughton protocol, or a cycle
ergometer, using a 10-Watt/min ramp protocol.12 Functional exercise capacity was
measured at baseline by peak oxygen consumption (peak VO2).11 Blood samples were
collected from a peripheral vein into EDTA-containing tubes, centrifuged immediately
and stored at −70°C. 11 All samples were obtained on the same day but prior to exercise
testing at the baseline, 3-month, and 12-month visits.13 Assays for all biomarkers were
performed using commercially available assays (Roche Diagnostics, Inc.) at the Duke
University central core laboratory.13 Socio-demographic and clinical history
characteristics were self-reported at baseline and patients completed the EuroQol-5D
(EQ-5D) as a measure of baseline health status.11
The HF-ACTION randomized control trial was approved by all relevant
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institutional review boards at the participating centers and the coordinating center.11 This
study was also approved by institutional review boards at the University of Pennsylvania
and Duke University.
Biomarker measures
High-sensitivity C-reactive protein (hsCRP) (mg/L) was selected as a marker of
inflammation because it is associated with heart failure severity.14,15 N-terminal pro btype natriuretic (NT-proBNP) (pg/mL) was selected as a marker of myocardial stress and
hemodynamic congestion because it is released in response to ventricular dilation,
hypertrophy and wall tension16 and increases with the severity of ventricular
dysfunction.17 NT-proBNP is also used routinely in the clinical management of patients
with heart failure and is an indicator of heart failure progression.13,18,19 In addition,
standard, reproducible and cost-effective assays are available for both biomarkers,
making them useful for prognostication.20,21 Both assays were also available in the HFACTION repository. Troponin was initially considered for this analysis, but was not
included because there were concerns about the analytic sensitivity and lack of variability
(zero-inflation) of the assay.
Statistical Analysis
In the preliminary analysis, descriptive statistics of frequency, central tendency and
dispersion over time were used to describe hsCRP and NT-proBNP independently.
Mean values of ln(hsCRP) and ln(NT-proBNP) values were compared between the
exercise training and usual care groups using analysis of covariance (ANCOVA),
controlling for baseline biomarker values and treatment allocation. Heterogeneity within
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each biomarker was further examined using histograms, box-, dot- and spaghetti-plots.
Consistent with previous HF-ACTION publications,13,22 raw values of NT-proBNP and
hsCRP were log-transformed to approximate normality.
The primary aim of this study was to identify common and distinct patterns of
change in ln(hsCRP) and ln(NT-proBNP). We chose to use growth mixture modeling to
facilitate a multi-marker, multi-mechanism analysis of the serum biomarkers of systemic
inflammation and myocardial stress.23-26 Though traditionally biomarkers have been
considered individually,16 multi-marker strategies are now recommended to improve risk
stratification and prediction in chronic heart failure.16,27,28
Figure 4.1 Conceptual Model
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Growth mixture modeling is a model-based naturalistic approach used to identify
distinct and common patterns of change over time within one or more measures (Figure
4.1). Growth mixture modeling allows for the identification of previously unobserved
patterns of change that have unique means, variances and homogeneous within-pattern
growth. The benefits of this modeling approach specific to this study are that multiple
patterns can be identified, missing data are handled with full-information maximum
likelihood estimation, and patterns are not reliant on equally spaced time intervals.29
Model selection was guided by the procedures explained by Ram and colleagues29 and
detailed in Table 4.1.
Table 4.1: Model fit criteria for latent class models
1

The Lo-Mendell-Rubin adjusted likelihood ratio test (p<0.05), indicating additive
information from models with k vs. k-1 patterns of change

2

Parametric bootstrapped likelihood ratio test (p<0.05), indicating additive information
from models with k vs. k-1 patterns of change

3

Bayesian Information Criteria and Akaike information criterion, with smaller numbers
indicating better comparative fit

4

Convergence (model entropy closer to 1.0)

5

The proportion of the sample in each pattern of change (not less than 5% of the sample)

6

Posterior probabilities (average probability of belonging in “most likely” pattern of change
closet to 1.0)

Individual growth mixture models for ln(NT-proBNP) and ln(hsCRP) were
identified and integrated into a single biomarker latent class model, which was
characterized by three distinct biomarker patterns. Baseline characteristics of the patterns
were described using medians (interquartile ranges) or means (SD) and frequencies
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(proportions) where appropriate. Comparisons of characteristics among the biomarker
patterns were made using χ2 analysis or one-way analysis of variance depending on levels
of measurement.
The second aim of the study was to identify socio-demographic and clinical
predictors of the individual unfavorable biomarker patterns of change. A model
comparison approach30 was applied throughout the model building process starting with
covariates associated in bi-variate analyses with the outcome variable (p<0.05). Next, a
priori factors were added and factors associated with the outcome using a forward
(starting with an empty model) and backwards (starting with a full model) stepwise
selection approach were added. Variables were eliminated conservatively in a sequential
approach if they had a p-value over 0.20. Factors that were considered in the models but
were not significant and did not contribute to the robustness of the model were removed.
The covariates included in the final model were the following 17 variables:
randomization to the exercise intervention or usual care, gender, race, age, heart failure
etiology, baseline creatinine, baseline peak VO2, body mass index (BMI), pain and
anxiety (assessed with the EQ-5D), diabetes, hypertension, taking a loop diuretic,
implantation of a pacemaker, bi-ventricular pacer or implantable cardioverterdefibrillator, treatment with an angiotensin-converting-enzyme inhibitor (ACE) or
angiotensin II receptor blocker (ARB). BMI was evaluated as a categorical variable and
continuous linear, quadratic and log transformed variable. The continuous linear form of
the variable was included in the model because neither the quadratic nor the log
transformed continuous variables were statistically significant.
Multinomial and logistic regression were used to identify predictors of observed
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patterns and relative risk ratios (RRR), odds ratios (OR) and 95% confidence intervals
(CI) were quantified and reported. Level of significance was set to p<0.05. Model fit was
compared among multiple models using a χ2 likelihood ratio test, pseudo R2, AIC, and
BIC tests as well as post-estimation fit statistics. StataMP v11.2 (College Station, Texas)
was used for descriptive and comparative statistics, multinomial regression and logistic
regression models. All mixture modeling was completed using Mplus (version v.7.0, Los
Angeles, CA). ANCOVA models that used the baseline biomarker value as the single
covariate were used to test for differences between the usual care and intervention
groups’ mean ln(NTproBNP) and ln(hsCRP) values at baseline, 3-and 12-months,
respectively.
Results
Baseline characteristics for this study cohort are reported in Table 2. Overall, the
median age was 58 years, the majority of the sample was male (73%), NYHA class II
(71%) with a median left ventricular ejection fraction (LVEF) of 24. Just over one-third
of participants had a history of diabetes (34%) or previous myocardial infarction (39%)
and approximately two-thirds had hypertension (60%). The vast majority of participants
in this study were treated with evidence-based therapies, including over 95% on an ACE
or ARB. Almost 50% of the sample was on a statin medication and almost 14% had an
implanted biventricular pacemaker.
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Table 4.2: Baseline demographic and clinical characteristics by biomarker patterns of change at baseline n=320
Variables (%, median/IQR)
Treatment group, no (%)
Usual care
Exercise training
Age, median (IQR)
Female sex (%)
Race n=315 (%)
Black or Other
White
New York Heart Association class (%)
II
III/IV
Ischemic etiology of heart
failure (%)
Diabetes mellitus (%)
Previous Myocardial Infarction (%)
Hypertension (%)
Atrial fibrillation or atrial flutter (%)
Clinical values, median (IQR)
Left ventricular ejection fraction
Systolic blood pressure,
mm Hg
Diastolic blood pressure, mm Hg

Overall
N=320

Lowest/improving
n=197

Elevated/stable
n=108

Elevated/
worsening
n=15

p-value
0.29

157 (49)
163 (51)
58 (51, 67)
86 (27)

92 (47)
105 (53)
59 (51, 69)
48 (24)

55 (51)
53 (49)
57 (52, 65)
36 (33)

10 (67)
5 (33)
57 (43, 64)
2 (13)

112 (36)
203 (64)

66 (34)
127 (66)

41 (38)
66 (62)

5 (33)
10 (67)

0.15
0.12
0.76

0.15
226 (71)
94 (29)
167 (52)

145 (74)
52 (26)
96 (49)

69 (64)
39 (36)
63 (58)

12 (80)
3 (20)
8 (53)

0.27

108 (34)
126 (39)
194 (60)
64 (20)

69 (35)
80 (41)
113 (57)
36 (18)

33 (31)
40 (37)
74 (69)
23 (21)

6 (40)
6 (40)
7 (47)
5 (33)

0.64
0.83
0.09
0.34

24 (21, 30)
112
(102, 130)
70 (61, 80)

25 (21, 30)
113
(102, 130)
70 (60, 80)

25 (20, 30)
110
(99, 130)
70 (62, 78)

24 (18, 29)
112
(100, 122)
68 (60, 74)

0.50
0.71
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0.81

Sodium at baseline, mEq/L
Creatinine at baseline, mg/dL, n=294
BUN, mg/dL, n=292
Beck Depression Index II, n=318
Baseline use of medications and
devices (%)
ACE inhibitor or ARB
B-blocker
Loop diuretic
Statin
Implantable cardioverterdefibrillator
Pacer
Biventricular pacemaker
Functional measures (median,
IQR)
Peak oxygen consumption,
mL/kg/min
Body mass index, kg/m2,
Six minute walk test, m (n=312)
EuroQol-5D (%)
Question 4: Pain/Discomfort (n=317)
No pain or discomfort
Moderate pain
Extreme pain

139 (138,141)
1.2 (1.0, 1.5)
20 (15, 27)
8 (4, 15)

140 (138, 141)
1.1 (1.0, 1.4)
19 (15, 25)
7 (4, 15)

139 (138, 141)
1.2 (1.0, 1.5)
22 (15, 31)
8 (4, 15)

139 (136, 140)
1.2 (0.9, 1.6)
22 (15, 27)
13 (5, 7)

0.33
0.13
0.23
0.16

305 (95)
299 (93)
241 (75)
156 (49)
118 (37)

189 (96)
183 (93)
135 (69)
98 (50)
63 (32)

102 (94)
101 (94)
94 (87)
50 (46)
48 (44)

14 (93)
15 (100)
12 (80)
8 (53)
7 (47)

0.78
0.56
0.001*
0.79
0.07

61 (19)
44 (14)

33 (17)
20 (10)

24 (22)
20 (19)

4 (27)
4 (27)

0.39
0.042*

15.2
(12.2, 17.8)
30 (26, 35)
384.0
(314.9, 440.2)

15.6
(13.1, 18.2)
29 (25, 33)
384.8
(320.0, 441.9)

13.4
(11.3, 16.9)
32 (28, 38)
384.0
(306.6, 438.9)

14.5
(12.8, 16.9)
20 (26, 35)
356.0
(306.0, 423.7)

0.002*
<0.001*
0.40
0.22

149 (47)
161 (51)
7 (2.2)

102 (52)
90 (46)
4 (2.0)
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41 (39)
62 (59)
3 (28)

6 (40)
9 (60)
0 (0)

Question 5: Anxiety (n=318)
0.54
Not anxious
187 (59)
118 (61)
62 (57)
7 (47)
Moderately/Extremely
131 (41)
77 (39)
46 (43)
8 (53)
anxious
Data are complete for all 320 participants unless otherwise indicated, p-values indicate difference in mean values across biomarker
subgroups for continuous variables. Abbreviations: IQR: interquartile range; BUN: blood urea nitrogen; ACE: angiotensin-convertingenzyme; ARB: angiotensin II receptor blocker *p-values are significant (<0.05) between the biomarker patterns
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Baseline socio-demographic and clinical characteristics were compared
between the original parent cohort and this subgroup. In general, the subpopulation
was representative of the parent cohort, but there were significant differences in the
proportions of patients in NYHA class II at baseline in the sample versus total
population (71% versus 63%, p=0.008). There were no statistically significant
differences between the means in the usual care and intervention groups for ln(NTproBNP) between baseline and 3 months (p=0.499) or baseline and 12 months
(p=0.471). There were also no differences in ln(hsCRP) from baseline to 3 months
(p=0.168) or baseline to 12 months (p=0.193) between the usual care and intervention
groups (Figure 4.2). Thus, growth mixture modeling was used to further identify and
describe potential underlying patterns.
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Figure 4.2 HsCRP and NT-proBNP for exercise training and usual care groups

Identification of Multiple Patterns of Change in Biomarkers Over Time
Three statistically independent and clinically meaningful biomarker patterns of
NTproBNP and hsCRP were identified (model entropy: 0.79, Lo-Mendell Rubin test pvalue=0.016) (Figure 4.3). Based on the observed characteristics of NT-proBNP and
hsCRP, the first pattern of change (n=197 [61%]; average posterior probability = 0.923)
was labeled “lowest/ improving.” That is, patients classified in the lowest/improving
pattern had the lowest levels of NT-proBNP and hsCRP at baseline, and there were
significant declines in both NT-proBNP (p=0.006) and hsCRP (p<0.001) over the course
of 12-months. The second pattern of change (n=108 [34%]; average posterior probability
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= 0.872) was labeled “elevated/stable.” Patients classified in the elevated/stable pattern
had higher hsCRP (p<0.001) and similar NT-proBNP levels (p=0.885) compared with the
lowest/improving pattern at baseline. In the elevated/stable pattern, there were slight
improvements in hsCRP over the 12-month follow-up period (p=0.017). The third and
smallest pattern of change (n=15 [5%]; average posterior probability was 0.900) was
labeled “elevated/worsening” because patients fitting this pattern had the highest levels
of NT-proBNP at baseline that did not change over time (p=0.827), and hsCRP increased
significantly over 12 months (p<0.001).
Figure 4.3 Bio-marker patterns
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Identification of Biomarker Pattern Determinants
Determinants of the elevated/stable and elevated/worsening biomarker patterns
from the multinomial regression are presented in Table 4.3, (model χ2=90.71, p<0.001,
pseudo R2=19.51%). Participants randomized to the exercise therapy intervention were
77% less likely (RRR: 0.23, p=0.037) to be in the elevated/worsening compared to
lowest/improving pattern. The risk of being in the elevated/worsening pattern was also
almost six times higher (RRR: 5.84, p=0.033) for participants who had a bi-ventricular
pacemaker prior to baseline, and over 1.5 times (RRR: 1.68, p=0.005) higher for each
unit increase in serum creatinine at baseline. The absolute difference in mean creatinine
at baseline was 0.5 higher in the elevated/worsening compared to the lowest/improving
pattern.
Table 4.3: Multinomial regression model predicting elevated/stable and
elevated/worsening patterns of change
Variable

Relative Risk
Ratio

95%
Confidence
Interval

p-value

*Predictors of the elevated/stable pattern
Exercise group

0.53

0.29-0.99

0.045

Loop diuretics

3.00

1.29-7.00

0.010

Hypertension

2.52

1.28-4.96

0.008

Ischemic etiology

2.22

1.08-4.51

0.028

Pain

1.80

0.99-3.26

0.054

Body mass index, kg/m2

1.08

1.02-1.13

0.005

Peak Vo2, mL/kg/min

0.92

0.85-1.00

0.057

Diabetes

0.44

0.23-0.86

0.017
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†Predictors of the elevated/worsening pattern
Exercise group

0.23

0.06-0.92

0.037

Bi-ventricular pacer

5.84

1.16- 29.5

0.033

Baseline creatinine

1.68

1.17-2.42

0.005

* These results compare the elevated/stable to lowest/improving pattern
† These results compare the elevated/worsening to lowest/improving pattern

Participants in the exercise intervention group were 47% less likely (RRR: 0.53,
p=0.045) to be in the elevated/stable compared to lowest/improving biomarker pattern.
Participants with diabetes were also less likely to be in the elevated/stable pattern
(p=0.017). Participants who were taking a loop diuretic had three times the risk (RRR:
3.0, p=0.010) of being in the elevated/stable, compared to lowest and improving pattern.
Likewise, participants had over double the risk of being in the elevated/stable pattern if
they had hypertension (RRR: 2.52, p=0.008) or heart failure of ischemic etiology (RRR:
2.22, p=0.028). Each additional unit of BMI was associated with an 8% increase (RRR:
1.08, p=0.005) in the likelihood of being in the elevated/stable pattern.
The results of the logistic model, which combined the elevated/stable and
elevated/worsening and compared them with the lowest/improving pattern, were
consistent with the multinomial results (Table 4.4). Once again, being in the exercise
group provided a 51% protective effect (OR: 0.49, p=0.018) compared to the usual care
group for not being in the combined elevated/worsening pattern. Consistent with the
previous model, participants with diabetes were less likely to be associated with the
worse biomarker pattern (p=0.026). The odds of being in the combined
elevated/worsening pattern were over two times higher for patients with heart failure of
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ischemic etiology (OR: 2.13, p=0.030), hypertension (RR: 2.05, p=0.028) or for those on
loop diuretics (OR: 2.38, p=0.026). The odds of being in the combined
elevated/worsening pattern were also 8% higher for each unit increase in BMI (OR: 1.08,
p=0.003). The variables in the model offer fair prognostication for the combined
elevated/worsening pattern (area under the curve: 0.78).

Table 4.4: Predictors of the combined elevated/worsening compared to
lowest/improving pattern
Variable

Odds Ratio

95% Confidence Interval

p-value

Exercise group

0.49

0.27-0.89

0.018

Ischemic etiology

2.13

1.08-4.24

0.030

Loop diuretic

2.38

1.11-5.11

0.026

Hypertension

2.05

1.08-3.89

0.028

Body mass index

1.08

1.03-1.13

0.003

Diabetes

0.48

0.25-0.91

0.026

Discussion
Using the growth mixture modeling, we identified a deleterious biomarker pattern
characterized by elevated myocardial stress and inflammation and a favorable pattern
characterized by lower myocardial stress and decreasing inflammation over 12-months.
Exercise therapy was protective for not having the elevated/worsening pattern of change
in biomarkers over time. This finding supports the potential for exercise therapy to
contribute to slowing or preventing the progression of heart failure.31
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The finding that there are no mean differences in mean ln(NT-proBNP) or
ln(hsCRP) over time between the exercise and usual care group are consistent with the
study by Ahmad and colleagues that used a sample of 928 participants from the HFACTION study.22 Ahmad and colleagues reported that exercise training (measured by
volume of exercise) was not associated with numerical decreases in NT-proBNP and
hsCRP from baseline to 3-months.22 In an effort to further explain the relationship
between these biomarkers (NT-proBNP and hsCRP) and exercise therapy, this study used
growth mixture modeling to identify distinct multi-marker biomarker patterns. This
methodology is especially relevant for a heterogeneous heart failure population, where
being able to identify distinct sub-groups (or patterns) is clinically informative. When
NT-proBNP and hsCRP were combined into distinct multi-marker patterns, we identified
an elevated/worsening pattern with rising hsCRP over 12-months. The characteristics of
this pattern may partially explain why there was not a statistically significant mean
reduction in hsCRP in the exercise therapy group compared to usual care. The study
findings reported here are consistent with results from the Cardiovascular Health Study
(CHS), in which deFilippi and colleagues reported a protective effect of moderate
physical activity on the risk of developing heart failure, neurohormonal activation
(measured by NT-proBNP) and cardiac injury (measured by Troponin T).32
One predictor of the elevated/worsening pattern of change was having a biventricular pacemaker. More participants with a bi-ventricular pacer were also classified
as NYHA III/IV, indicating that having a bi-ventricular pacer may be a proxy for heart
failure severity. Higher baseline creatinine was also associated with over a one-and-a-half
fold risk of having the elevated/worsening pattern. Worsening renal function is defined as
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absolute creatinine elevation of 0.1 to 0.5 mg/dL.33 The difference between the
lowest/improving and elevated/worsening was 0.5 mg/dL, which is a clinically
meaningful difference because of the association with 6-month mortality, readmission
and functional decline.33 This finding is consistent the Breathing Not Properly study
where there was a weak but significant correlation between estimated glomerular
filtration rate (eGFR) and BNP.34 Likewise, in a study reported by Anwaruddin and
colleagues, lower eGFR was associated with higher proBNP.35 The relationship between
renal function and natriuretic peptides is complex and may be explained by elevated
intravascular volume, atrial pressure, systemic pressure or by ventricular mass.36
When comparing the elevated/stable pattern, in which there was an elevation in
hsCRP, but not NT-proBNP, with the lowest/improving pattern, once again, participants
randomized to the exercise therapy intervention were much less likely to have the
deleterious biomarker pattern. Hypertension was associated with a two and a half fold
risk of being in the elevated/stable compared to lowest/improving pattern, along with
other measures of severity—being on a loop diuretic or having heart failure of ischemic
etiology. Many patients with reduced renal function also have hypertension, which can
cause left ventricular hypertrophy and elevated natriuretic peptides.36 Hypertension and
hsCRP have also been associated in other studies due to shared mechanisms of oxidative
stress and endothelial dysfunction.37 Specifically, hsCRP is known to attenuate nitric
oxide production and decrease endothelial nitric oxide synthase expression leading to
vasoconstriction and atherothrombosis.20 The association between elevated hsCRP and
hypertension is consistent across multiple racial and ethnic groups.38,39
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Higher BMI was also associated with the elevated/stable biomarker pattern. The
inverse relationship between BMI and NT-proBNP has been reported in many other
studies,40-44 explaining why obesity was associated with the elevated/stable and not the
most unfavorable pattern—elevated/worsening. One theory for this inverse association is
that there is increased clearance of NT-proBNP by type C natriuretic peptide receptors on
adipocytes.45 In obese patients, natriuretic peptides are still routinely used for diagnostic
purposes, but at lower cutoff levels.43
Diabetes was also associated with a 56% lower risk of being in the elevated/stable
compared to lowest/improving biomarker pattern. This may be explained by a higher
proportion of diabetic patients being on a statin medication compared to non-diabetics
(59% versus 43%). Statins are associated with reduced hsCRP in diabetic patients.46 The
apparently protective effect of diabetes may be due to chance, or it might be related to the
fact that diabetic participants were less likely than non-diabetic participants to have
ischemic etiology (44% versus 56%). However, controlling for statin use and ischemic
vs. non-ischemic etiology in post-hoc models did not change the strength of the
relationship between diabetes and the risk of having the hazardous patterns of change in
these biomarkers. More research is needed to further explore associations among diabetes
and other comorbidities in heart failure and the systemic inflammatory and myocardial
stress responses to exercise.
Strengths and Limitations
The growth mixture modeling analytic approach was a major strength of this
study because it allowed for the identification of previously unobserved biomarker
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patterns of change. As such, it is a useful analytic tool for helping to explain the
heterogeneity in response to exercise therapy that is common among patients with heart
failure. Another strength of this study was that it built off the results of the Ahmad
study,22 demonstrating how different types of biomarker analyses can help to explain how
exercise may be able to slow or prevent the progression of heart failure.31
One potential limitation of this study is its generalizability because it was
conducted on a random sample of the biomarker sub-study with near-complete data. This
random sample is representative of the larger HF-ACTION trial population. Though it is
unlikely that our results were solely a function of sample selection, it is possible that if
this analysis were done on in the entire dataset that the results would be different. The
relative risk reduction reported in this study should be interpreted with caution because
the elevated/worsening pattern was relatively small and the overall sample size of the
study was modest. Although we successfully identified statistically distinct biomarker
subgroups and corresponding predictors, further testing in a larger sample may increase
the precision of the estimates. Given that the measure of exercise was randomization to
the exercise intervention, rather than quantity, it is likely that the protective effect of
exercise would be stronger if adherence were accounted for. The final limitation is that
the exercise therapy group tended to have lower NT-proBNP at baseline, though this
difference was not statistically significant (p=0.083). This slight imbalance at
randomization is unlikely to account for the protective effect of exercise therapy reported
in this study.
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In summary, these study results indicate that exercise therapy may prevent
worsening inflammation and myocardial stress in patients with stable heart failure and
help counteract the pathophysiological processes of the heart failure progression through
multiple biologic mechanisms. These results contribute to the body of knowledge on
exercise as a preventative and therapeutic intervention for patients with heart failure.
There are many related avenues for future research around exercise and heart
failure, including further elucidation of mechanisms of benefit, identifying which
biomarkers are modified by exercise, quantifying the dose of exercise needed to achieve a
benefit, and identifying ways to engage heart failure patients in exercise.31 There is also a
strong need to identify different exercise regimens for patients with heart failure and
prevalent comorbid conditions such as type 2 diabetes. In the future, multi-marker
biomarker analyses of exercise interventions may also be able to clarify which patients
can be expected to benefit from exercise by demonstrating the mechanism by which
exercise slows the progression of heart failure.31
Acknowledgements: We would like to thank Dr. Stephen Ellis from Duke University for
developing the HF-ACTION dataset, approving the data analysis plan and summary and
reviewing the final manuscript. We would also like to acknowledge Dr. Houry Puzantian
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Abstract
Lack of engagement in self-care is common among patients needing to follow a
complex treatment regimen, especially patients with heart failure who are affected by
comorbidity, disability, and the side effects of poly-pharmacy. In response, clinical
practice guidelines recommend using behavioral approaches to engage patients in selfcare. The efficacy of motivational interviewing to improve self-care in patients with heart
failure remains understudied. We are conducting a brief, nurse-led motivational
interviewing randomized controlled trial to address behavioral and motivational issues
related to heart failure self-care. Participants who are randomized to the intervention
group receive both home and phone-based motivational interviewing sessions over 90
days. Participants in the control group receive care as usual. The purpose of the study is
to test the efficacy of a MI intervention on self-care, physical HF symptoms and quality
of life. This article presents the study design and methods and plans for statistical
analysis for Motivational Interviewing Tailored Interventions for Heart Failure (MITIHF). Study findings will contribute to the literature on the efficacy of motivational
interviewing to promote heart failure self-care.
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Introduction
Heart failure is a cardiovascular syndrome affecting more than 5.1 million
Americans. It is growing in prevalence with 670,000 new cases diagnosed each year,1
especially among patients older than 80 years.2 The management of heart failure is
complex because it often occurs in the context of multiple comorbid conditions.2 Each
comorbid condition requires specific self-care, making prioritization a persistent
challenge. One method that has been efficacious for decreasing symptom prevalence and
preventing re-hospitalization is the promotion of self-care.3 Initiating effective self-care
for early signs and symptoms of heart failure may help patients have a better quality of
life3 and delay the onset of an acute decompensation.4,5
Self-care for patients with heart failure has been defined as a naturalistic decisionmaking process comprised of both self-care maintenance and self-care management.6,7
Self-care maintenance involves choosing positive health practices that may help to
prevent an acute exacerbation (e.g. taking medication as prescribed, consuming a low-salt
diet, staying physically active, and monitoring daily weight). Self-care management
builds on these routine behaviors and includes critical decision-making and follow-up
actions around managing signs and symptoms when they occur (e.g., taking an extra
diuretic for shortness of breath).6-8 Heart failure self-care must be adapted to the
individual because each person has his or her own symptom experience and functional
disability.
Early evidence from a mixed-methods pilot study9 suggested that a motivational
interviewing (MI) intervention was beneficial for adults with heart failure by improving
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their self-care.9 Riegel and colleagues reported that the effectiveness of the intervention
was due to the MI approach.9 Building upon these earlier findings, MITI-HF was
designed improve heart failure self-care maintenance behaviors using MI.
The article describes the study design and research methods used to evaluate the
intervention (Clinicaltrials.gov ID MITI-HF_EGKMF). We designed Motivational
Interviewing Tailored Interventions for Heart Failure (MITI-HF) to examine the
feasibility and efficacy of a MI intervention to improve patients’ self-care. The primary
aim of the study is to test the feasibility and preliminary efficacy of MITI-HF for its
impacts on heart failure self-care over 90 days. The secondary aim is to examine the
impact of MITI-HF on secondary outcomes of physical HF symptoms and quality of life
over 90 days.
Background
To improve self-care, this study uses a tailored MI approach. Traditionally,
patient education programs focus on disseminating didactic information. Information
alone is rarely sufficient to influence symptom management behaviors,10-12 especially in
the case of heart failure where there are often competing co-morbidities including
diabetes mellitus (38%), hypertension (73%), kidney disease (45.9%) and obesity
(46.8%),2 in addition to chronic obstructive pulmonary disease, depression, and cognitive
impairment.13-15 Overall, educational approaches for improving heart failure self-care
have been developed and tested with little impact on heart failure outcomes.16-18
Tailored interventions are designed to address the individual characteristics of
persons within a sample.19 Conceptually, this is similar to the Lauver et al definition of
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individual-centered interventions, which addresses either characteristics and experiences
or individuals’ goals or preferences.20 In this case, the intervention is targeted to
hospitalized patients with chronic heart failure and then tailored specifically to patient’s
goals and to match individuals’ unique self-care maintenance or management needs. We
postulated that a tailored MI approach would help patients with heart failure address
behaviors that are problematic by increasing internal motivation to engage in specific
self-care behaviors chosen by the patient.
MI is grounded in client-centered counseling, cognitive-behavioral therapy, and
social cognitive therapy.21 MI also incorporates the Transtheoretical Model of Behavior
Change, which assesses a patient’s readiness to change behavior and develops strategies
to move toward taking action to change behavior.22 MI integrates the concepts of
relationship building from humanistic therapy23 with active strategies oriented towards
stages of change.22 The main characteristics of motivational interviewing are: expressing
empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy.24
The interviewer maintains a nonjudgmental approach and allows the patient to determine
the need for behavioral change, rather than offering unsolicited advice on the need for
change. The interviewer only explores ways to implement change once the patient
expresses the desire and confidence to change. The goal of MI is to help individuals work
through inherent ambivalence present in problematic or unhealthy behaviors,24,25 and to
help them verbally express their own reasons for or against change using a
nonjudgmental, empathetic and encouraging tone.26 MI can help people identify how
their current behaviors conflict with their ability to achieve personal health goals,
especially in the context of low readiness to change.26
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MI was initially developed for the treatment of substance abuse.27-29 Due to its
strong theoretical base and empirical support, MI is now used for patients with a wide
variety of unhealthy behaviors including illicit drug abuse, eating disorders, asthma, HIV
risk behavior, and gambling.30 It is also used for cardiovascular diseases, including heart
failure in acute and outpatient settings.9,31-33 Brodie and colleagues used MI to increase
physical activity among older adults with heart failure,31 as well as general and disease
specific quality of life.32 MI has specifically been used to improve heart failure self-care
in small pilot studies;9,34 however, larger studies are needed to build the body of evidence
and confirm the preliminary albeit promising results of these small pilot trials.
Theoretical Frameworks
The Situation Specific Theory of Heart Failure Self-care6 is used as the guiding
theoretical framework for the study. The Model for Tailoring Behavioral Interventions19
was used to plan, implement and evaluate the tailored intervention, and MI is the
mechanism for delivery.
Intervention development
The Model for Tailoring Behavioral Interventions19 was used to develop and test
the tailored intervention. The Model for Tailoring Behavioral Interventions has five steps:
1) understanding, 2) assessing, 3) planning, 4) implementing and 5) evaluating. The first
step in designing the tailored intervention was selecting the individual characteristics on
which the intervention would be tailored.19 In this study tailoring was based on physical,
mental, and behavioral health characteristics. Physically, all participants in the study have
had a recent hospitalization for acute decompensation of heart failure. Behavioral
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decision-making is at the heart of self-care so participants’ self-care scores were assessed
using the Self-Care of Heart Failure Index (SCHFI) v 6.2.7,35 The intervention was
planned based on areas that patients were deficient in according to the SCHFI as well as
their self-defined goals. For example, if a patient’s goal was: “to be able to attend my
grandson’s football games this fall,” the nurse tailors the intervention to specific physical
activity needs. Implementation includes conducting a randomized controlled trial. The
study outcomes are common across individuals despite the fact that each intervention is
tailored to participants’ unique goals and areas that they self-defined as needing growth.
Usual care
All participants are enrolled from the hospital and both the intervention and the
control groups receive patient education materials in the hospital. Patient education sheets
were designed by Krames StayWell for a 6th grade or below literacy level, according to
the Fog Index (Table 5.1).36 The photographic images in the materials are commensurate
with the demographics and culture of the study population. For instance, the “Busting
Barriers” sheet pictures three generations of African American males to reinforce the
benefits of social and familial support. All of the educational sheets targeted goal
behavior changes through participant interaction, such as writing down the names of
support people who would help them see habits that might block their progress toward
change. Individuals randomized to the UC did not receive any other intervention.
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Table 5.1 Patient Education Materials
Patient Education Sheet

Busting Self-Care Barriers

Educational content areas
Helps patients to identify possible challenges to self-care
in order to prevent them from becoming barriers;
recommendations include being active, reducing salt,
limiting fluid, taking an extra water pill, and calling a
healthcare provider.

Breaking Down Your
Barriers

Describes how to take steps to improve self-care, identify
support people, and identify benefits of self-care
behaviors.

Dealing with Heart Failure
Symptoms

Helps patients record baseline information such as weight,
walking distance, and amount of stairs able to climb
before becoming short of breath.

Watch for Changes

After baseline information has been identified, this is a
worksheet describes how to monitor symptom changes. It
also offers tips for limiting salt and fluids.

Stay Active to Help Your
Heart

Focuses on how to incorporate activity into a daily
routine, including how to choose an activity and warning
signs of overexertion.

Adding Activity to Your
Day

Includes tips for making activity part of your day, and for
how to keep it fun by walking with friends or reading a
book while on an exercise bike.

My Heart Failure
Symptom Chart

My Symptom Action Plan

This chart is for recording daily weight, change from
baseline weight and changes in symptoms.
This worksheet is for recording action plans for different
scenarios of worsening heart failure symptoms, including
swelling, increased shortness of breath, and weight gain of
2 or more pounds in 1 day.

Motivational Interviewing Intervention
Heart failure specialist nurses provide the MI intervention. The nurses conduct
one home-based MI intervention session followed up by three MI phone calls over 90
days. The intervention begins with a conversation about the participant’s self-identified
goals. During the home intervention, the nurses focus on self-care areas that the
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participant identifies as high priority. During that visit the participant sets specific goals,
which the nurses follow up with and reinforce over the follow-up phone calls. Based on
our prior work with motivational interviewing, we anticipate that one 60-minute session
and three to four follow-up phone calls scheduled over the following few months are
adequate to deliver this intervention.9
Interventionist Training
Before starting the study, the bachelor or masters degree prepared nurse
interventionists received two full days of training covering detailed aspects of MI theory
and heart failure-specific self-care techniques and skills. The principal investigators and
an expert in MI supervised both training days. The nurses practiced the techniques of MI
through numerous role-play scenarios with one another and the facilitators.
Treatment Fidelity
Treatment fidelity is monitored throughout the intervention by recording all of the
intervention sessions. All audiotaped intervention sessions are transcribed, and analyzed
to assess treatment fidelity, a methodological strategy used to monitor and enhance the
reliability and validity of the intervention.37 Prior to implementation of the protocol, a
standardized rubric was developed based on the intervention manual to score adherence
to the study protocol including the use of the principles of MI. This provided a
mechanism for providing corrective feedback to the interventionists regarding deviations
from the study protocol. Each audio recording is reviewed to determine the proportion of
the intervention elements covered by the nurse interventionist using a checklist. In
addition to ongoing feedback with the interventionists, a psychologist trained in MI also
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reviews random transcripts and provides feedback to the interventionists on the quality of
MI as well as adherence to the protocol.
Study Design
MITI-HF is a prospective, single blinded, pilot feasibility randomized single-site
trial. The target sample size is 65 participants; however, to account for an estimated 35%
attrition rate, the target number for recruitment is 100 participants. The target sample size
was calculated based on a 2:1 randomization scheme (intervention: control) with 90%
power (5% alpha) to detect a difference of 80% versus 50% (intervention and control
group) of scoring over 70 on the SCHFI, which is the cut-off for adequate self-care35 at
three months. The power analysis was performed using G*Power 38 and confirmed with
PASS.39
Procedures
To achieve balance in the study arms, randomization is performed using
minimization,40 stratifying participants on NYHA class and gender. Randomization to the
intervention or usual care group occurs after the informed consent form is signed and a
cardiologist scored New York Heart Association (NYHA) Functional Class interview
(Figure 5.1).
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Figure 5.1: MITI-HF flow chart

Identify potential participant

Present study opportunity to
potential participant
If agree, obtain informed consent
Screen for health literacy &
cognition
If eligible, complete NYHA,
SCHFI, Med Record Review.
Provide patient education
worksheets.

Randomization

MI Intervention

Usual Care

2 week post-hospital phone call
to complete KCCQ, HFSPS,
Socio-demographics

2 week post-hospital phone call
to complete KCCQ, HFSPS,
Socio-demographics

Home intervention and followup phone calls
90 day phone call to complete KCCQ,
HFSPS, SCHFI, Hospitalizations &
Medical Events, Intervention
satisfaction survey

108

90 day phone call to complete KCCQ,
HFSPS, SCHFI, Hospitalizations and
Medical Events

Data Collection
Medical history, including comorbidities and heart failure characteristics, are
obtained from patients’ electronic medical records. Kansas City Cardiomyopathy
Questionnaire (KCCQ) and Heart Failure Somatic Perception Scale (HFSPS) data are
collected at baseline approximately two weeks after hospital discharge via phone call by
research assistants blinded to study group. Over time, we realized that the 6-item
screening tool for cognition was not adequate to pick up some cases of severe cognitive
impairment. In response, a second screening was put in place two weeks after discharge
and before the baseline questionnaires were completed. If participants had no recollection
of the study, or signing the informed consent during the baseline call, they were excluded
from the study on the grounds that they had cognitive impairment severe enough to meet
exclusion criteria. Research assistants collect follow-up data at 90 days on the SCHFI,
KCCQ, HFSPS and self-reported clinical events.
Sample
Adults with heart failure are enrolled into the MITI-HF study from two urban
inpatient cardiology units. To be included, participants have to: 1) be hospitalized with a
primary or secondary diagnosis of heart failure, 2) be able to read and speak English, 3)
be 18 years of age or older 4) live in a setting where they can independently engage in
self-care, 5) live within 30 miles from the university hospital 6) have at least adequate
health literacy, 7) have symptomatic HF (NYHA II-IV) and 8) be willing to participate.
Exclusion criteria included: 1) being on a Milrinone drip, 2) being on a list for an
implanted ventricular assist device or heart transplant, 3) pregnancy, 4) psychosis and 5)
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cognitive impairment with the inability to participate in the intervention or complete the
study instruments. Study enrollment took place from January 2012 to December 2013.
Ethics
The institutional review board at the affiliated University approved the study
protocol. Written informed consent and Health Insurance Portability and Accountability
Act authorization are obtained from all interested participants. All research assistants are
trained in HIPAA confidentiality and the protection of human research subjects. All
procedures are in accordance with the Declaration of Helsinki.41
Measurement of Variables
Self-care is measured using the SCHFI v. 6.2, a 22-item, interviewer-administered
instrument that quantifies HF patients’ self- care maintenance, self-care management, and
self-care confidence (self-efficacy).7,35 Each scale score ranges from 0 to 100; higher
scores indicate better self-care. Quality of life is measured with the KCCQ, which has 23
items that can be quantified into five subscales: physical limitations, symptoms, quality
of life, social interference, and self-efficacy. Each domain-specific subscale and the
overall clinical summary score range from 0 to 100.42 Higher scores indicate better
quality of life. Acute physical symptom recognition is measured with the HFSPS. Scores
are calculated by summing responses; higher values reflect worse physical symptom
distress.
Data Analyses
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Standard descriptive statistics of frequency, central tendency, and dispersion will
be used to describe all measures of the study at baseline. Comparisons of socio
demographic and clinical characteristics between the intervention and usual care groups
at baseline will be reported using Student’s t, Pearson χ2 analysis or ANOVA where
appropriate. Differences between groups in improvements in self-care will be quantified
using t-tests without assuming equal variance; Cohen’s d is calculated as a standardized
index of effect size. Repeated measures tests are used within subjects. Analyses will be
conducted using StataSE (College Station, Texas) using intention-to-treat. Effect sizes
will be calculated with G Power. 38
Conclusion
This article describes the development and implementation of MITI-HF, a tailored
MI intervention to support heart failure self-care. The significance of this study is that it
tests an innovative, MI intervention that has high potential to be integrated into
transitional care discharge planning services. We anticipate that using this MI approach
can help patients with heart failure focus on their internal motivation to change in a nonconfrontational, patient-centered, collaborative way. It also affirms their ability to
practice competent self-care relevant to their personal health goals. Future articles will
present the results of the study and implications for heart failure research and clinical
practice.
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Abstract

Background: Self-care has been shown to decrease symptom prevalence, improve
quality of life, delay the onset of acute decompensation and prevent hospitalization for
patients with heart failure (HF). The efficacy of using motivational interviewing (MI) to
improve self-care is unknown.
Methods and Results: We conducted a randomized controlled trial to test the
comparative efficacy of a tailored MI intervention versus usual care in improving HF
self-care behaviors, physical HF symptoms and quality of life. The intervention consisted
of a single home visit and 3-4 follow-up phone calls by a nurse over 90 days. A total of
67 participants completed the study (mean age 62 ± 12.8 years), of which 54% were
Black, 30% were female, 84% had class III/IV symptoms, and 63% were educated at a
high school level or less. Both the intervention and usual care groups had significant
improvements in self-care maintenance and confidence (all p<0.01); the intervention
group also had a significant improvement in self-care management (p<0.01). However,
participants in the intervention group had a 9-point greater improvement in self-care
maintenance compared with the usual care group (p=0.026) at 90 days. There were no
differences between the groups in self-care management, confidence, physical HF
symptoms or quality of life at 90 days.
Conclusions: Patients with HF who received the MI intervention had statistically
significant and clinically meaningful improvements in self-care maintenance over 90
days that exceeded that of usual care. Overall, MI is an effective approach for improving
self-care maintenance.
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Introduction
Heart failure (HF) affects more than 5.1 million Americans1 and costs the United
States $39.2 billion annually.2 HF is currently the most common reason for the
hospitalization of Medicare recipients.3-6 The costs for preventable readmissions are
estimated to be about $17 billion or 20% of Medicare’s hospital payments.7 Patients with
HF are frequently admitted to the hospital because they experience exacerbations in
symptoms with fluid retention, shortness of breath, and fatigue on exertion.8 Considering
the increasing prevalence, cost and social burden to patients and their families,
interventions that incorporate self-care with effective medical therapy are critical to
optimize patient health and improve patient outcomes.9-11
Self-care has the potential to reduce hospitalizations and improve quality of life.
Several studies have examined the impact of self-care education on patient-oriented and
clinical outcomes including self-care behaviors,12 self-efficacy,13 quality of life,13-16
physical activity,17 health status,18 hospitalizations,19,20 mortality,16 myocardial stress,21
and systemic inflammation.22 Overall, there has been an apparent lack of effectiveness of
self-care education on clinical outcomes. One reason is that patients face a number of
prohibitive barriers to mastering self-care skills and knowledge, including cognitive
impairment, excessive daytime sleepiness, low-health literacy,23-25 and poor motivation.26
Motivational interviewing (MI) has been proposed as a client-centered strategy to engage
patients in self-care,12,27 and improve self-efficacy and readiness to change.
The purpose of this randomized controlled trial (Motivational Interviewing
Tailored Interventions for Heart Failure [MITI-HF]) was to test a tailored MI intervention
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designed to improve self-care compared to usual care. The primary study outcome was
change in self-care maintenance (i.e. daily behaviors like taking prescribed medications,
restricting fluid and dietary sodium intake, participating in health-seeking behaviors, and
monitoring for HF symptoms). The main hypothesis was that HF patients enrolled in the
group receiving a uniquely tailored MI intervention would improve in self-care after 90
days. Secondary outcomes included physical HF symptoms and quality of life.
Methods
Study design
MITI-HF was a prospective, single-blinded, pilot randomized controlled trial. The
University’s Institutional Review Board approved the study, which actively enrolled
participants from January 2012 to December 2013. Detailed description of study methods
including participant eligibility, recruitment procedures and data collection have been
registered (Clinicaltrials.gov MITI-HF_EGKMF), reported in a study design paper28 and
are summarized here. The target recruitment size was 100 participants, a sample size
calculated to provide 90% power (5% alpha) to detect a difference of 80% versus 50%
(intervention and control group) likelihood of scoring over 70 on the Self-Care of Heart
Failure Index (SCHFI) v.6.2 at 90 days. The power analysis was performed using
G*Power 29 and confirmed with PASS.30
Participants
One hundred participants were randomized to receive the MITI-HF intervention
or usual care after a HF-related hospitalization. The study inclusion and exclusion criteria
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are shown in Table 6.1. Potential participants were approached during an inpatient HFrelated hospitalization at a University affiliated urban hospital. All eligible patients were
screened for health literacy,31 cognitive impairment (using a six-item screener derived
from the Mini Mental Status Exam (MMSE)),32 baseline self-care (using the SCHFI
v.6.2),33 and a standardized interview to assess New York Heart Association (NYHA)
functional class.34 Those who met the inclusion criteria and agreed to participate provided
written informed consent. At the end of this visit, all participants received a set of
educational fliers related to identifying and addressing self-care barriers, dealing with
heart failure symptoms, maintaining a lower sodium diet and an active lifestyle.
Participants were then randomized by minimization35 to one of two intervention groups
with a 2:1 randomization ratio stratified by NYHA functional class and gender.36
Table 6.1. Eligibility Criteria
Inclusion Criteria
1. Hospitalized with a primary or secondary
diagnosis of HF
2. Able to read and speak English
3. 18 years of age or older
4. Living in a setting to independently engage
in self-care
5. Living within 30 miles from the University
Hospital
6. Have at least adequate health literacy
7. Symptomatic HF (NYHA I-IV)

Exclusion Criteria
1. Current treatment with milrinone
2. On a list for an implanted VAD or heart
transplant
3. Pregnancy
4. Psychosis
5. Cognitive impairment- the inability to pass
the six-item screener or complete study
instruments
6. Inability to provide informed consent

Abbreviations: HF: heart failure, NYHA: New York Heart Association, VAD: ventricular assist device

Baseline data were collected approximately two weeks after hospital discharge. A
research assistant (blinded to study group allocation) called participants to obtain sociodemographic information and to administer the baseline Kansas City Cardiomyopathy
Questionnaire (KCCQ) and Heart Failure Somatic Perception Scale (HFSPS).
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Approximately 90 days after completion of the intervention, participants were called to
complete the follow-up questionnaires (SCHFI, KCCQ, HFSPS). If the first follow-up
call was unsuccessful, the research assistant would try every 3 to 5 days for up to 60
days. If there was no contact with the participant after 60 days from the expected followup date, the participant was considered lost to follow-up.
Intervention Description
As described in detail elsewhere,28 participants assigned to the intervention group
received a MI tailored intervention that included a home-based MI intervention and 3-4
follow-up phone calls over the course of 90 days. Participants assigned to the usual care
group continued with their usual care without further intervention. We chose this model
of delivery for the intervention based on the Situation Specific Theory of Self-Care
theoretical framework and our previous research.12 During the home visit the nurse
worked with the participant using a MI approach to identify specific client-centered goals
related to HF self-care. Together they developed a client-directed plan for accomplishing
the goals, which were reinforced in the follow-up phone calls. A case study details how
the nurse used the MI intervention to increase patient motivation and develop a plan for
incorporating self-care behaviors into the daily routine of one participant.37
Study Measures and Outcomes
Self-care. Self-care was measured using the SCHFI v. 6.2, which is a 22-item,
interviewer-administered instrument that quantifies self-care maintenance, self-care
management, and self-care confidence (self-efficacy) for patients with HF.33,38 The
SCHFI was written for a sixth grade reading level and takes approximately 5 to10
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minutes to complete. Scores on each scale were standardized to range from 0 to 100—
higher scores indicate better self-care. A score of 70 or greater in each self-care scale
score is considered adequate and an improvement of 8 points is considered a clinically
significant improvement.33 Cronbach’s α is not recommended as a measure of reliability
for these scales because both self-care maintenance and self-care management scales are
multidimensional.39 Using more appropriate coefficients, for the self-care maintenance
scale, the reliability coefficients ranged from 0.75 to 0.83, depending on which
coefficient was used. For self-care management, reliability coefficients ranged from 0.66
to 0.77. Self-care confidence is unidimensional and the various reliability coefficients,
including Cronbach’s alpha, ranged from 0.84 to 0.90.39 In a recent exploratory factor
analysis, the comparative fit index construct validity scores were: 0.92 for self-care
maintenance; 0.95 for self-care management and 0.99 for self-care confidence.40
Concurrent validity of the SCHFI v 6.2 has been demonstrated by comparing it to the
European Health Failure Self-care Behavior Scale (r= -0.65, p<0.001).40
Quality of life. Quality of life was measured with the KCCQ, which has 23 items
that can be quantified into five subscales: physical limitations, symptoms, quality of life,
social interference, and self-efficacy. Each domain-specific subscale and the overall
clinical summary score range from 0 to 100 (higher scores indicate better outcomes).41 In
another population of patients with heart failure the internal consistency of the KCCQ is
reported as being high (Cronbach’s α 0.92).42 Tests of construct validity for the KCCQ
have strong associations with NYHA class, SF-36 and the six minute-walk-test.41
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Acute Physical Heart Failure Symptoms. Acute physical HF symptoms were
measured with the HFSPS. This scale asks how much participants were bothered by
common symptoms of HF during the previous week. The responses to the 18-items range
from 0 (I did not have this symptom) to 5 (extremely bothersome).43 Scores were
summed with higher values indicating worse physical symptom distress. The reported
reliability of the HFSPS scale is 0.90.44 Validity was demonstrated when the two
domains, dyspnea and early/non-specific congestion were associated with survival at 180
and 365-days.45
Participant characteristics. Age, gender, comorbid conditions, prescribed
medications, diagnostic lab tests, and echocardiogram results were obtained from the
medical record. During baseline interviews research assistants obtained information on
race/ethnicity, insurance status, years of education, perceived and general health from the
participant. General health was measured by rating their health now compared to a year
ago. Responses ranged from 1 (much worse) to 5 (much better) compared to a year ago.
Participants were also asked about the quality of their social support and responses
included fair, satisfactory, good or very good.
Traditional questions about income characteristics (sources, amounts received)
have been wrought with a wide range of bias46 and random error in both government
surveys and other types of research.47 So, income was measured with the question,
“Financially, would you say you are: comfortable; have more than enough to make ends
meet; have enough to make ends meet; or do not have enough to make ends meet?”
Data Analysis
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Standard descriptive statistics were used to describe all study covariates at
baseline. Independent sample t-tests were conducted for continuous variables and chisquared tests for categorical variables. We assessed whether randomization achieved
balance across study covariates between the two study groups for baseline demographic
and clinical characteristics. We also measured whether there were any differences in
participants who completed the study compared to those who were lost to follow-up
(response bias). Gender specific analyses were completed to further explain differences
between groups.
We used t-tests to assess for change in self-care maintenance and self-care
confidence, physical HF symptoms and quality of life between baseline and 90 days
within and across groups. We used chi-squared tests for differences in proportions to
assess for improvement in self-care management because only a subset of participants
was symptomatic and able to respond to these questions. Data analyses were conducted
using StataSE 13.1 (College Station, Texas).
For the primary outcome (self-care maintenance) a model comparison approach48
was applied throughout the model building process starting with covariates associated in
bi-variate analyses with the outcome variable (p<0.05); then a priori factors were added.
Factors that were considered in the models but were not significant and did not contribute
to the robustness of the model were removed. The final model for predictors of change in
self-care maintenance included the following eight variables: intervention group, general
health, sleep apnea, financial status, coronary artery disease, gender, support quality, and
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having a home health nurse. These eight variables were adjusted in the main analyses of
group differences over time.
Results
The CONSORT diagram (Figure 6.1) reflects participants who were screened,
enrolled, randomized and included in the analyses for both self-reported and objective
outcomes between the two groups. A total of 100 participants were enrolled and 67
completed the study of self-reported outcomes. For these outcomes, including the
primary outcome of self-care, the overall attrition rate was 33%, (13% in the usual care
group and 42% in the intervention group) consistent with other studies of patients with
HF.49 There were no statistically significant differences in the socio-demographic or
clinical characteristics of participants who completed versus did not provide self-reported
follow-up data. There were also no statistically significant differences in the self-care,
physical HF symptom or quality of life at baseline between those who completed and did
not complete the study. Thus, the missing at random assumption was not violated.
Participants in the study had a mean age of 62 years and ranged in age from 23 to
86 years (Table 6.2). This sample of adults was predominantly male (60%) and Black
(>50%). This was a fairly low educated group with most having no more than a high
school education. Many participants were unemployed or disabled, one-third reported
financial distress, and three-quarters reported poor or fair health. Clinically, 30% had
ischemic etiology and almost half had systolic HF with a reduced left ventricular ejection
fraction (LVEF). Overall, participants in the study were functionally compromised
(83.6% NYHA Class III or IV). Participants were also on numerous medications (12 SD
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±5.5) and lived with multiple comorbidities (5.5, SD ± 2.8). In terms of support, most
people lived with another person and reported having good or very good support.
Figure 6.1 CONSORT diagram showing participant study flow
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Table 6.2a. Baseline socio-demographic characteristics by randomization group
Randomization group (mean +/- SD or %)
Variables
Age
Gender
Female
Male
Married/Partnered
Race
Black
White
Education
<High School
College/Grad School
Total years education
Employment Status
Employed/Retired
Unemployed/Disabled
Financial Status
Comfortable/Enough
Not enough
Insurance Type
Government
Commercial/HMO
Health Perception
Poor/Fair
Good/Very
Good/Excellent
Health in General
Worse/Same
Better/Much Better
Home Health Nurse
Provider Specialty
Medicine/Cardiology
HF Specialist
Lives with another
Support Quality

Overall
Total (N=67)

Control
Total (N=26)

Intervention
Total (N=41)

p-value
0.397
0.130

62

(13.4)

63 (12.6)

60 (13.9)

20
47
31

(29.9)
(70.2)
(46.3)

5 (19.3)
21 (80.8)
15 (57.7)

15 (36.6)
26 (63.4)
16 (39.0)

36

(53.7)

17 (65.4)

19 (46.3)

31

(46.3)

9 (34.6)

22 (53.7)

0.135
0.128

0.233
42
25
13

(62.7)
(37.3)
(2.3)

14 (53.9)
12 (46.2)
13 (2.2)

28 (68.3)
13 (31.7)
13 (2.4)
0.834

32
35

(47.8)
(52.2)

12 (46.2)
14 (53.9)

20 (48.8)
21 (51.2)

45
22

(67.2)
(32.8)

16 (61.5)
10 (38.5)

29 (70.7)
12 (29.3)

0.435

0.419
50

(74.6)

18 (69.2)

32 (78.1)

17

(25.4)

8 (30.8)

9 (22.0)
0.088

49

(73.1)

16 (61.5)

33 (80.5)

18

(26.9)

10 (38.5)

8 (19.5)
0.746

37
30
49

(55.2)
(44.8)
(73.1)

15 (57.7)
11 (42.3)
18 (69.2)

22 (53.7)
19 (46.3)
31 (75.6)

16
51
51

(23.9)
(76.1)
(76.1)

8 (30.8)
18 (69.2)
21 (80.8)

8 (19.5)
33 (80.5)
30 (73.2)
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0.566
0.292

0.477
0.241

Fair/Satisfactory
Good/Very Good
Nurse Interventionist
Nurse 1
Nurse 2

11
56

(16.4)
(83.6)

6 (23.1)
20 (76.9)

5 (12.2)
36 (87.8)
0.902

51
16

(76.1)
(23.9)

20
6

(76.9)
(23.1)

31 (75.6)
10 (24.4)

Table 6.2b. Baseline Clinical Factors by Randomization Group
Randomization group (mean +/- SD or %)
Variables
NYHA Functional Class
Class I/II
Class III/IV
HF Etiology
Ischemic
Non-ischemic
Other

Overall
Total (N=67)

Control
Total (N=26)

Intervention
Total (N=41)

0.125
11
56

(16.4)
(83.6)

2
24

(7.7)
(92.3)

20
31
16

(29.9)
(46.3)
(23.9)

9 (34.6)
9 (34.6)
8 (30.8)

9 (22.0)
32 (78.1)
0.299
11 (26.8)
22 (53.7)
8 (19.5)

HF Type
Systolic
Diastolic
Mixed
Ejection Fraction (%)
Total comorbidities
Pacemaker (any type)
Medications (total)
Beta Blocker
Ace Inhibitor
ARB
Statin
Diuretic
Baseline Lab Values
Sodium
Hemoglobin
Creatinine
BUN

p-value

0.478
32
13
22
35
5.5
21
12
57
33
7
40
59

(47.8)
(19.4)
(32.8)
(16.8)
(2.8)
(31.3)
(5.5)
(85.1)
(49.3)
(10.5)
(59.7)
(88.1)

135.7 (15.6)
11.6 (1.9)
1.7 (1.3)
34.8 (29.0)

10
6
10
37
5.4
8
12
24
11
4
16
23

(38.5)
(23.1)
(38.5)
(16.5)
(3.5)
(30.8)
(5.6)
(92.3)
(42.3)
(15.4)
(61.5)
(88.5)

137.6 (2.8)
11.8 (1.8)
2.0 (1.9)
30.5 (23.8)

22
7
12
34
5.6
13
12
33
22
3
24
36

(53.7)
(17.1)
(29.3)
(17.2)
(2.4)
(31.7)
(5.6)
(80.5)
(53.7)
(7.3)
(58.5)
(87.8)

134.5 (19.9)
11.4 (1.9)
1.5 (1.3)
37.6 (31.9)

0.586
0.689
0.936
0.782
0.186
0.365
0.293
0.807
0.936
0.434
0.370
0.139
0.338

Abbreviations:HF: heart failure, NYHA: New York Heart Association, ARB: Angiotensin II Receptor
Blockers, BUN:blood urea nitrogen, PE: Pulmonary Embolis, DVT: Deep vein thrombosis,
CAD: coronary artery disease , COPD: chronic obstructive pulmonary disease, CV: cardiovascular disease
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Self-care Outcomes
Overall, self-care maintenance (mean: 78.5, SD ±12.7) was adequate for the entire
sample at 90 days (Table 6.3). Within the intervention group, there was significant
improvement in self-care maintenance (p<0.01) over 90 days. Within the usual care
group there was also significant improvement in self-care maintenance (p<0.01).
However, absolute change in self-care maintenance was greater in the intervention group
compared to usual care (12.1 vs 19.7 points, Cohen’s d= 0.44). Though the effect size
was moderate, the difference between groups was not initially statistically significant.
After adjusting for gender, general health, sleep apnea, financial status, coronary artery
disease, support quality and having a home-care nurse, there was a statistically and
clinically significant 8.9 point increase (95% CI: 1.0 -16.7) in the MI group compared to
the usual care group (p=0.03) at 90 days.
Overall, at baseline, 6.0% of the sample was asymptomatic and thus unable to
complete the self-care management scale (3.9% in the usual care group and 7.3% in the
intervention group; p=0.56). At follow-up, 32.8% of the sample was asymptomatic, but
there was no difference between the groups in achieving asymptomatic status (p=0.44). In
the intervention group 90% improved in self-care management and in the usual care
group 73% improved in self-care management (p=0.07).
In both groups self-care confidence improved more than 20 points (p<0.001)
(Table 6.3). There were no statistically significant differences in improvement in selfcare confidence between the two study groups (p=0.31), although the absolute change in
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self-care confidence was higher in the intervention compared to usual care group (26 vs
21 points, Cohen’s d=0.26).
Physical HF symptoms, clinical summary score and quality of life
At baseline the mean score on the HFSPS, the measure of physical HF symptoms,
was 19.9 (SD ± 19.4). At 90 days the mean HFSPS was 17.9 (SD ± 18.06) with no
differences between (p=0.63) or within groups (MI: p=0.29; usual care: p=0.83). The
mean score for men in the MI group decreased 7 points (95% CI: 0.58 to 13.50; p= 0.03)
—indicating symptom improvement. There were no differences in the usual care group
for men or for women in either group.
The mean KCCQ clinical summary score at baseline was 56.1 ±24.6 (Table 3).
The within group change over 90 days was significant (p=0.01) although the mean
change of 10.3 points between baseline and follow-up was not different between the
groups (p=0.67).
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Table 6.3. Self-care at Baseline and 90-days follow-up for participants in the usual
care or Motivational Interviewing Groups
Variable
Self-care maintenance
Baseline
90-days
Absolute change
Self-care management
Baseline
90-days
Absolute change
Self-care confidence
Baseline
90-days
Absolute change
KCCQ QOL
Baseline
90-days
Absolute change
KCCQ CSS
Baseline
90-days
Absolute change
HFSPS Total Score
Baseline
90-days
Absolute change

Intervention
mean (SD)

Usual care, ,
mean (SD)

t-value (p) c

59.9 (16.3)
79.6 (11.5)
19.7 (16.0) a

64.7 (16.9)
76.8 (14.5)
12.1 (18.3) a

1.2 (0.250)
-0.9 (0.383)
-1.8 (0.077)

50.1 (26.3)
48.4 (37.1) b
1.7 (39.9)

56.7 (26.5)
41.2 (38.1)
15.6 (48.0)

1.0 (0.321)
-0.8 (0.442)
-0.6 (0.564)

54.6 (22.2)
81.2 (18.0)
26.6 (20.8) a

61.4 (18.5)
83.0 (16.3)
21.6 (16.8) a

1.3 (0.204)
0.4 (0.690)
-1.0 (0.309)

50.81 (29.27)
61.59 (26.67)
10.77 (28.15)

60.25 (28.01)
65.06 (28.48)
4.81 (21.37)

1.3 (0.196)
0.5 (0.614)
-0.9 (0.359)

54.60 (24.49)
63.94 (24.82)
9.34 (23.91)

58.50 (25.12)
69.41 (23.89)
11.86 (20.86)

0.6 (0.531)
0.9 (0.382)
0.4 (0.665)

21.56 (19.23)
18.76 (17.28)
-2.81 (16.79)

17.31 (19.65)
16.58 (19.52)
-0.73 (17.14)

-0.9 (0.385)
-0.5 (0.634)
0.5 (0.627)

a

: significant improvement (p<0.01) from baseline to 90-days by paired t-tests
: N=41= because the follow-up score was not recorded for people who were asymptomatic at 90 days
(n=26)
c
p-values are for differences between group t-tests
b

The combined mean KCCQ quality of life score for all participants was 54.5 (SD ± 29.0)
at baseline and 62.93 (SD ±27.2) at follow-up (Table 6.3). The absolute change in quality of life
of 10.7 points from baseline to 90 days within the MI group was statistically significant (p=0.02)
compared to the change of 4.8 points in the usual care group (p=0.26) but the difference in quality
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of life between groups was not significantly different (p=0.36) at 90 days. In a specific gender
analysis, men within the MI group had an improvement of 12 points ±31.46 (p=0.05) in

quality of life, while there were no significant differences for men in the usual care group
or for women in either group.
Discussion
The results of this randomized controlled trial designed to test the efficacy of a MI
intervention shows that using a MI approach improved self-care maintenance in this
sample of adults with HF. Further, there was evidence of a trend in improved self-care
management. These results support our earlier conclusion that motivating people with HF
to take more control over their health with self-care can help them achieve optimal health
outcomes.50
The finding that the MI intervention improved self-care maintenance is consistent
with others who have used MI as a tool to improve physical activity in various patient
populations living with chronic illness, including older adults with HF,51 chronic
obstructive pulmonary disease (COPD),52 fibromyalgia53 and chronic pain.54,55 More
specifically, MI is currently being tested to improve patient engagement and motivation
for self-management in patients with COPD,52 as a management strategy to sustain the
clinical benefits of exercise for fibromyalgia53 and to improve disability, pain intensity,
(pain-specific) self-efficacy, motivation, and quality of life for people with chronic
musculoskeletal pain.55 Tse and colleagues also reported improved change scores for
quality of life, self-efficacy, physical and psychological function and compliance with
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exercise in a group receiving MI with a physical exercise intervention compared to a
usual care group.54
In MITI-HF, quality of life improved in both study groups over 90 days; however,
there were no statistically significant differences between groups. Brodie and colleagues
also reported improvement in quality of life over 5 months after being in the MI physical
activity intervention.13 One of the reasons for the differences between MITI-HF and the
Brodie study may be due to the use of different quality of life measurement tools. They
used the Medical Outcomes Short Form-36 Health Survey and the Minnesota Living with
Heart Failure questionnaire while we used the KCCQ in MITI-HF. The Brodie study also
had a longer follow-up period. In addition, physical activity is known to improve quality
of life14 whereas in MITI-HF participants chose a variety of behavior changes, some of
which are associated with a decrease in socialization options—including maintaining a
low sodium diet—which may negatively impact quality of life. Beckie and colleagues
also designed a study to promote healthy behavior change for women with coronary heart
disease using MI and they reported improvement in global quality of life in the MI
compared to usual care group.56,57 Differences in study results between MITI-HF and the
Beckie randomized controlled trial may be due to the fact that the Beckie study was
powered to detect changes in quality of life (the sample size was much larger (n=225)). In
addition, the intervention was much longer (6-months), more intensive (three, 60-min inperson MI sessions and 10 weeks of psychoeducational sessions) and gender-specific.
The patient-population was also less sick than the MITI-HF sample of patients with HF.
The quality of life measures in the two studies were also different. Beckie et al. used
Multiple Discrepancies Theory and Self-Anchoring Striving Scale questionnaires to
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measure quality of life compared to the KCCQ used in MITI-HF. It is also possible that
in a functionally compromised population of patients with severe HF that there is a
ceiling effect of how much quality of life can improve over time due to the impact of
worsening of disease severity.
In MITI-HF, the MI intervention did not improve participant’s self-care
confidence (self-efficacy) over time compared with usual care. In contrast, there is early
evidence from a study by Paradis and colleagues that reports improvement in selfefficacy using an MI approach in patients with HF.58 In the Paradis study, patients
received a similar dose of MI from a nurse (one face-to-face MI intervention followed up
by two telephone conversations) and yet there was no improvement in self-care
maintenance but there was improvement in self-care confidence over 1-month.
Differences in study design between the two studies may explain the differences in selfcare outcomes, including length of patient follow-up (30 versus 90 days) and at least one
or two more follow-up MI phone calls in MITI-HF by the nurse.
MI has also been tested in other chronic disease patient populations to improve
self-efficacy and clinical outcomes such as weight reduction in obese youth59 and
physical activity in aging adults.60 In the Walpole study with obese youth, there were no
statistically significant differences between the MI and social skills training groups for
improvement in weight loss or self-efficacy; however, participants in both groups showed
significant increases in self-efficacy and a trend of decreased body mass index z-scores.59
Lilienthal and colleagues did a telephone-based MI intervention to increase physical
activity and self-efficacy in aging adults.60 The MI group reported higher self-efficacy for
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physical activity at six months follow-up.60 Once again, differences in the study results
between MITI-HF and the Lilienthal study may be due to differences in disease severity
between patient populations (those in MITI-HF study were much more functionally and
physically compromised) and a longer follow-up period in the Lilienthal study (90 days
versus 6 months).
Strengths/Limitations
Strengths of this study include minority participation (over 50%), with women
well represented. One limitation was that objective measures of self-care behaviors (e.g.
pedometer for exercise) were not used in this study. The largest limitation was the loss of
participants to follow-up and specifically the difference in attrition for the self-reported
outcomes between the usual care and MI group. One of the proposed reasons for
differential dropout was that the MI group had at least 60% more points of contact than
the usual care group, thus increasing opportunities for dropout.
Conclusions
MI is a successful approach for improving self-care maintenance for patients with
HF. Future studies should consider using a MI approach to improve self-care.
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CH VII-SUMMARY AND CONCLUSIONS
Introduction
Patient outcomes related to heart failure (HF) continue to be poor, including high
hospitalization rates, early death, exorbitant costs, intractable symptoms, and low quality
of life (QOL).1-4 To improve patient outcomes, better management strategies that
incorporate optimized medical therapy with effective self-care are critical.5-7 This body of
work addressed several critical elements of HF self-care. The Situation Specific Theory
of Heart Failure Self-Care was used to frame these studies.8 This theory conceptualizes
HF self-care as having two core components, choosing positive routine health practices
(‘self-care maintenance’) and making decisions around the management of signs and
symptoms of HF when they occur (‘self-care management’).8,9
The primary purpose of this body of work was to strengthen the evidence base for
self-care by studying two understudied aspects of HF self-care maintenance—consuming
a low-sodium diet and exercising. The secondary purpose was to test the efficacy of a
tailored motivational interviewing (MI) approach to improve self-care, QOL, physical HF
symptoms and clinical outcomes. The aims of these studies were to: 1) identify predictors
of high sodium intake, 2) identify distinct biomarker patterns and predictors of worst
biomarker patterns in response to exercise, and 3) test the efficacy of MI to improve HF
self-care. This final chapter provides a summary and discussion of each study aim and
concludes with recommendations for future research and implications for clinical
practice.
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Summary and Discussion of Principal Findings
Predictors and patterns of high sodium excretion using multiple analytic methods
The first aim was to identify predictors of high sodium consumption over time in
patients with HF (Ch. II). The principal findings are summarized in Table 7.1. In brief,
three factors were associated with excess sodium consumption, two of which, obesity and
diabetes mellitus, are modifiable by changing dietary food patterns. The study reported in
Ch. III is an extension of Ch II. Instead of setting a priori sodium levels based on Heart
Failure Society of America (HFSA) guidelines,10 naturally-occurring patterns of sodium
intake were driven by the study data. Two patterns of sodium consumption were
identified using growth mixture modeling (GMM), one that was much higher than
recommended (>4.4 g/day) and the other that was broadly adherent (2.4 g/day) with
current Institute of Medicine (IOM) recommendations.11 In this study, the predictors of
high sodium consumption were: 1) obesity, 2) diabetes mellitus and 3) younger age (< 65
years). These two studies provide a framework for targeting specific HF populations with
nutritional counseling and guidance.
Table 7.1 Principal Findings: Specific Aim 1
Specific Aim 1: Identifying predictors and patterns of high sodium intake using
multiple analytic methods
Studies
Principal Findings
Identifying predictors of
The adjusted odds of higher sodium excretion were
higher than recommended
higher for patients who were obese, had diabetes and
sodium intake in HF
for patients who were cognitively intact.
patients using a mixed
effect logistic analysis of
longitudinal data
Identifying subgroups of
Two distinct patterns of sodium intake were identified
sodium adherence in adults in patients with HF using GMM. Being overweight
with HF
and obese, less than 65 years of age or having diabetes
mellitus were associated with a 4-fold incremental
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increase in the likelihood of being in the higher than
recommended pattern of urine sodium.

In addition to taking medications as prescribed, dietary sodium restriction is the
most common self-care behavior recommended for patients with HF.12-14 As such, these
studies are an important contribution to the literature because they demonstrate that
patients with HF are consuming higher sodium intake than recommended and that
specific patient characteristics are associated with sodium consumption that is almost
double the recommended intake. Excess sodium consumption may be exacerbating
symptoms of HF and putting patients at higher risk for hospitalization and death.15
The topic of sodium restriction has come under intense debate following
conflicting reports about sodium restriction being either beneficial or harmful.16 Some
observational studies report an association between a lower sodium diet and improved HF
outcomes.15,17,18 Other studies report different results based on NYHA severity.18,19
Lennie and colleagues were the first to report differential event risk by HF severity based
on sodium intake.19 Patients with NYHA class III/IV were more likely to be
rehospitalized if they consumed ≥ 3g/day of dietary sodium, and patients with NYHA I/II
were more likely to be hospitalized if sodium intake was < 3 g/day.19 Similarly, Song and
colleagues reported differential event-free survival for patients with mild compared to
severe HF in response to three categories of sodium intake.20 They found that sodium
restriction < 2 g/day was associated with higher event risk for patients with NYHA Class
I/II and lower event risk for patients with NYHA Class III/IV.20 In another observational
cohort study by Pfister and colleagues, they reported a U-shaped association between
urine sodium excretion and risk of HF from the EPIC-Norfolk study.21
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In contrast, the results of some RCTs indicate that dietary sodium restriction may
actually cause harm.22-24 Paterna and colleagues enrolled 232 patients with HF (New
York Heart Association (NYHA) class II-IV, 55-83 years of age, ejection fraction < 35%
and serum creatinine < 2 mg/dl).23 Thirty-days after discharge, participants were
randomized to a diet of either 1.8 or 2.8g of sodium per day. In addition, the study
protocol included 250-500mg of furosemide twice daily and a 1-L fluid restriction. After
180 days the 2.8g sodium diet was associated with reduced admissions and lower
mortality and the 1.8g sodium diet was associated with worse renal function.23 These
study results were repeated in a larger sample.24 Another study also suggested that severe
sodium restriction is harmful in patients with reduced ejection fraction.22 Two limitations
of these findings were that all studies came from the same group in a localized region in
Italy and the results have not been replicated elsewhere. Due to the controversy between
the observational and randomized studies, the Institute of Medicine (IOM) examined the
evidence and now recommends a diet of no more than 2300 mg of sodium per day for all
adult Americans, including those with comorbidities who were previously singled out as
needing lower sodium thresholds (ie: diabetes mellitus and HF).11
While controversy has waged about the lower threshold of sodium consumption,
the reality is that most patients with HF consume far more than the maximum
recommended amount. The mean urine sodium excretion for the entire sample reported in
Chapters II & III ranged from 2770 mg/d (1750-3950 mg/d) at baseline to 2780 mg/d
(1900-3790 mg/d) at six months.25 These values are consistent with other studies that
report a mean consumption of 2671 mg/d26 and 3190 mg/d of sodium.27 The IOM’s cutoff of no more than 2300 mg/d is lower than any of the means reported in these studies of
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patients with HF. Given the context that the average adult American consumes
approximately 3,400 mg of sodium per day28 and that most patients with HF consume
more than the maximum recommended guidelines, the messaging to patients with HF
should be consistent--it is still a priority to consume a low-sodium diet.
Successfully advocating for sodium restriction will take a multi-faceted approach,
including policy advocacy to reduce sodium in processed foods, consumer education and
behavior change. Arcand and colleagues provide a good example of how to navigate the
common lack of awareness about food sodium content in patients with HF by developing
a Web-based sodium intake screening tool called the Salt Calculator, in which individuals
can quantify their sodium intake.29 In the future, genomic studies may also be able to
guide personalized sodium intake based on anthropomorphic measures.30
The strengths of the studies reported in Chapters II and III are that they both used
repeated measures of sodium excretion on the same individuals over a six-month period.
The study reported in Ch II also used robust and transparent imputation methods to
address potential bias from incomplete data. A limitation of the study reported in Ch II
was the selection of a binary cut-point for adherence to dietary recommendations based
on NYHA functional class scores published by the HFSA.10 In retrospect, this was an
overly restrictive cut-point that allowed for simple associations, but did not allow more
granular detail and analysis of sodium consumption patterns. One of the strengths of the
study reported in Ch III was that due to the use of GMM, the patterns of sodium intake
(or self-care maintenance) could vary naturalistically.
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The primary limitation of the studies reported in Chapters II and III is the
measurement of sodium intake using a 24-hour urine sodium collection. There have been
doubts about the validity of 24-hour urine sodium collection for patients with HF on
evidence-based pharmacotherapy, specifically diuretic medications, angiotensinconverting enzyme inhibitors, angiotensin receptor blockers and aldosterone
antagonists.31,32 In addition, 24-hour urine sodium collection is limited in that it only
captures sodium intake over 24 hours rather than over a longer time frame. There are also
limitations of self-reported sodium intake, including reports that it is not reliable among
patients with HF.33 In general, following a low sodium diet is often interpreted by
patients as not using salt for cooking, rather than reducing the consumption of highsodium canned, frozen or take-away food.33 Food diaries can also be subject to recall bias
and the impact of social desirability.34 Overall, despite the limitations of a 24-hour urine
sodium collection, it is still considered the gold standard for an objective measure of
sodium intake even for patients with HF on diuretics.35
While it is clear that very high sodium intake is not recommended for healthy
adults or patients with HF, it is still not clear: (1) what the lowest and safest range of
sodium intake is, (2) whether recommendations can be general or if they should be
tailored to individuals or targeted to specific sub-groups, and (3) what the most reliable
and valid approach is to measuring dietary sodium.30 Changes in policy should focus on
reducing excess sodium across the food environment so that consumers have more choice
in how much sodium is in their food,36 as well as raising consumer knowledge to identify
and avoid high sodium foods.
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Self-care maintenance: exercise and biomarkers
The second aim was to identify common and distinct patterns of change in serum
biomarkers of inflammation and myocardial stress and quantify the influence of exercise
therapy on patterns of change in a community-based sample of patients with HF. To
address this aim, an analysis was conducted with data from the Heart Failure: A
Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) RCT. The
principal findings are detailed in Table 7.2.
Table 7.2 Principal Findings: Specific Aim 2
Specific Aim 2: The primary aim was to identify common and distinct patterns of change in
serum biomarkers of high-sensitivity C-reactive protein (hsCRP) and N-terminal pro b-type
natriuretic (NT-proBNP) and quantify the influence of exercise therapy on the patterns of change.
Principal Findings
1. Three statistically independent and clinically meaningful biomarker patterns of
NTproBNP and hsCRP were identified and titled: “lowest and improving,” “elevated and
stable,” and “elevated and worsening.”
2. Participants randomized to the exercise intervention were 75% less likely to have the
elevated/worsening pattern of NT-proBNP and hsCRP

The sample of patients with HF in this sample were relatively young (58 years),
the majority were male (73%) with NYHA class II (71%). In this relatively high
functioning sample of patients with HF enrolled in an RCT, three distinct biomarker
patterns of inflammation and myocardial stress were identified. The most common
pattern, “lowest/improving” (61% of the sample), was the most favorable pattern because
it was characterized by the lowest levels of NT-proBNP and hsCRP at baseline and both
biomarkers declined over 12-months. The second pattern was labeled “elevated/stable”
(34% of the sample) and it was characterized by higher hsCRP and similar NT-proBNP
to the lowest/improving pattern. The third pattern “elevated/worsening” was the smallest,
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but most deleterious, (5% of the sample) characterized by the highest levels of NTproBNP and increasing hsCRP over 12-months.
Exercise was a protective factor for worse intermediary physiologic outcomes in
patients with HF. Participants who were enrolled in the exercise intervention were much
less likely (77%) to be in the elevated/worsening or elevated/stable pattern (47%).
Overall, exercise therapy has been advocated for patients with HF to improve functional
capacity37 and clinical outcomes.38 Moderate exercise is associated with a decreased risk
of clinical events.39 The results of this study support the benefits of exercise therapy as
being protective and contributing to slowing the progression of HF. Some of the
mechanisms for the protective effect of exercise may be improving myocardial
contractility, perfusion, endothelial dysfunction,40,41 angiogenesis,42 and coronary and
peripheral skeletal vessel dilation.43
The reported protective effect of exercise is particularly relevant in the context of
the recent decision by the Centers for Medicare & Medicaid Services to reimburse
cardiac rehabilitation for patients with stable, chronic HF.44 Now that cardiac
rehabilitation is reimbursable, there is a push for it to include broader self-care counseling
to improve education and skills around medication compliance and monitoring/managing
body weight.45 Because the benefits of exercise are limited by patient adherence, tailored
approaches to engage patients are critical for any improvement or benefit from exercise.
In addition, system-wide support should be put in place to get patients referred to cardiac
rehabilitation.45
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Motivational Interviewing Tailored Intervention for Heart Failure (MITI-HF)
The third aim of this body of work was to integrate the previous two aims into a
pilot RCT. Taking what was learned from Chapters II-IV we designed MITI-HF to test
the comparative efficacy of a tailored MI intervention in improving HF self-care
behaviors, physical HF symptoms, and QOL. The principal finding of MITI-HF was that
the MI intervention improved the primary outcome of self-care maintenance over and
above usual care even after controlling for demographic, clinical and health service
factors (Table 7.3).
Table 7.3 Principal Findings: Specific Aim 3
Specific Aim 3: Implement and evaluate MITI-HF for its impacts on HF self-care over 90 days.
Examine the impact of MITI-HF on secondary outcomes of physical HF symptoms and health
related quality of life over 90 days.
Principal Findings
1. MI was a successful approach for improving self-care maintenance. Participants in the MI
group had statistical and clinical improvements in self-care maintenance compared to the
usual care group.
2. There were no differences between the two study groups for self-care management, selfcare confidence, QOL or physical HF symptoms and response.

The results of MITI-HF demonstrated that a tailored MI intervention improved
self-care maintenance in a sample of adults with HF. The study sample was
predominantly Black; participants had multiple comorbid conditions and most were
functionally compromised. At baseline the overall mean self-care maintenance score for
this sample was adequate. At 90 days, there was significant improvement in self-care
maintenance (p<0.01) in both groups; however, the absolute change was greater in the
intervention compared to the control group. After adjusting for gender, general health,
sleep apnea, financial status, coronary artery disease, support quality and having a home148

care nurse, there was a statistically and clinically significant 8.9 point46 increase in selfcare maintenance in the MI group compared to the usual care group. These results
suggest that motivating people with HF to take more control over their health with selfcare can help them achieve optimal health outcomes.13
A variety of educational approaches have been designed to improve self-care in
patients with HF and results have been mixed.47-53 Albert and colleagues reported
improved self-care management behaviors and higher self-care scores (over 3-months) in
response to a video, which could be watched at home repeatedly over 3-months.50 In
contrast, another intervention using remote patient education through a TV-channel found
no differences in self-care behaviors over 288 days.51 Caldwell and colleagues tested a
simplified education intervention in a small sample of rural patients and found that daily
weighting was the only self-care behavior that improved over 3-months.52 Similarly,
Baker and colleagues tested a telephone education/counseling versus single-education
intervention and found that the “teach to goal” educational and behavioral support
program provided benefit for self-care behaviors (irrespective of literacy levels).47
Another study by Clark and colleagues also used an education support model and found
that it improved several health status and self-care outcomes, including functional status,
self-efficacy and self-care.49 Overall, there has been substantial heterogeneity in study
results of educational interventions on self-care outcomes.
Using skill-building rather than an educational approach, Dickson and colleagues
found that a community-based tactical and situational HF self-care skill development
delivered by lay health educators in community senior centers improved patients HF self149

care and knowledge but not health-related QOL.54 The findings from the Dickson and
colleague study are similar to MITI-HF, which reported improved self-care outcomes but
not QOL at 90 days.
MI has been used to improve self-care behaviors, including physical activity, in
older adults with HF.55 Tse and colleagues have used MI to improve physical and
psychological function and compliance with exercise.56 MI has also shown promise for
improving self-care in other chronic diseases, including chronic obstructive pulmonary
disease (COPD),57 fibromyalgia58 and chronic pain.56,59 MITI-HF built off a smaller pilot
study results by Riegel and colleagues that found 71% of participants reported improved
self-care in response to a MI intervention.60 Now MITI-HF is one of the larger studies to
date to specifically use MI to improve self-care in patients with HF. Philosophically, MI
is a promising approach to improve self-care because it is consistent with the underlying
value of self-are that patients should be pro-actively involved in the maintenance and
management of their own health and prevention of disease.
Given the challenge of enrolling Blacks in RCTs,61 a major strength of MITI-HF
is that it is generalizable to a population that has a high prevalence of HF62 and is underrepresented in HF research.63,64 In a mixed-methods study of 30 patients with HF,
Dickson and colleagues described themes that self-care is highly influenced by cultural
beliefs, such as HF being inevitable, attributed to stress and spirituality. Some self-care
maintenance behaviors were well supported by cultural beliefs (medication adherence)
whereas cultural preferences for specific foods were often not consistent with a low-
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sodium diet.65 Overall, there is a dearth of studies that test self-care interventions
specifically among Blacks.
One of the biggest challenges of MITI-HF was patient follow-up and assessment
of self-care outcomes. At the baseline phone call (post-hospitalization), 52 participants
were excluded from MITI-HF. Almost half were excluded because they were unable to
be contacted post-hospitalization, despite having contact information for the participant
and close relatives. Inability to contact participants was apparently due to lack of
continuity of housing, changing geographic locations and shifting support structures that
many of these patients face. In part due to this challenge of follow-up, there was a lack of
statistical power to detect changes in the secondary outcomes.
During the baseline phone call, 14% of patients were excluded prior to baseline
data collection due to cognitive impairment. This was an unanticipated study limitation
because severe cognitive impairment had been screened for using the 6-item screener66 in
the hospital. Participants had passed the six-item screener and yet at baseline did not
remember enrolling in the study. We characterized this as evidence of mild cognitive
impairment and participants were screened out of the study prior to any data collection.
In retrospect, the Montreal Cognitive Assessment (MoCA) would have been a better
cognitive screening tool. It is more sensitive and specific to mild cognitive impairment
and mild Alzheimer’s disease than the Mini-Mental State Exam (MMSE).67 According to
the results of MITI-HF and other studies of patients with HF,68,69 good screening for
cognitive impairment is important for the early identification of patients who may benefit
from a tailored disease management program.
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Cognitive impairment is highly prevalent among older patients hospitalized for
HF; estimates range from 25-50% of patients.70 This is consistent with estimates that 15%
of patients with HF have dementia and 24% have mild cognitive impairment.71 A recent
systematic review reports that patients with mild cognitive impairment have problems
performing self-care.68,72 Further research is needed on how cognitive impairment
specifically affects the ability to sustain attention, concentration, memory capacity, motor
speed and capacity to engage in executive functioning (problem solving and abstract
reasoning). Future research is also needed on strategies for engaging patients with HF and
cognitive impairment in better self-care because cognitive impairment has serious
implications for self-care,73 including being a mediator for the effect of poor physical
fitness on decreased functional independence in HF.74
Another study limitation of MITI-HF was that objective measures of self-care
outcomes were not included. Including a 6-minute walk test for physical activity and a
food diary or 24-hour urine sodium excretion for adherence to a lower sodium diet would
have strengthened the study. The primary outcome, self-care maintenance, was limited as
a self-report process outcome. The next step for this research, is having a fully powered
study to detect statistically significant differences between groups for clinical and health
status outcomes. In this study, although patient-reported outcomes such as physical HF
symptoms and QOL were measured, the study was not adequately powered to detect less
than very large changes in these measures over time.
Other study limitations include only two data collection points, limited follow-up
timeframe (90 days) and differential attrition for self-care outcomes between the study
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groups. More data collection points and a longer follow-up period would have allowed
for non-linear assumptions of longitudinal data over time. At the same time, longer
follow-up and more data points may have increased drop-out and missing data, which
was already the largest limitation of the study.
In a follow-up study to MITI-HF in Rome, Italy by Vellone and colleagues, an
additional study group is being added to include only HF patient informal caregivers.
According to a recent systematic review, informal caregivers play an important role for
patients with HF, assisting patients with both concrete and interpersonal activities.75
Results from a cross-sectional study indicate that having family member accompaniment
to routine medical visits is associated with higher self-care maintenance and
management.76 The impact of a patient-family partnership was tested in the Education
and Support Interventions to Improve Self-Care [ENSPIRE] study. The intervention
group of dyads received an intervention focused on dietary sodium intake and medical
adherence by a master’s-prepared research nurse trained in the study protocol.27 Dietary
sodium intake improved in the intervention groups compared to usual care, but
medication adherence did not improve.27 Another study by Vellone and colleagues sought
to describe the manner in which QOL and self-care vary within a couple dealing with
chronic HF.77 Higher self-care maintenance (measured with the SCHFI 6.2) was
associated with higher caregiver QOL.77 These results are consistent with MITI-HF, in
which better support quality was one of the strongest predictors of improvement in selfcare maintenance (Beta Coefficient: 11.5, 95% CI: 1.3, 21.6, p= 0.028). While the
involvement of caregivers, especially spousal caregivers, is ideal; some patients do not
have that level of caregiving support. In a study with veterans receiving care at a Veteran
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Affairs Medical Center, veterans reported that having an advocate—a member of the
healthcare team, friends or family, helped them optimize their self-care management.78
Given the challenge of cognitive impairment and the impact on caregivers, it is an
important contribution to the literature that the MITI-HF follow-up study will include
caregivers in the intervention and caregiver outcome data.
Summary
Overall, the results of this body of work are a significant contribution to the
literature on HF self-care maintenance. There is now evidence that: 1) many patients with
HF consume a high sodium diet; 2) modifiable predictors of consuming a high sodium
diet include being obese or overweight and having diabetes; 3) non-modifiable predictors
include younger age (< 65 years); 4) exercise was protective for being in the worst
biomarker pattern of inflammation and myocardial stress; 5) a tailored MI intervention
was feasible for patients with HF and improved patients’ self-care maintenance. This
body of work answered a number of research questions using biomarker data and
multiple methodologies. This work also combined existing secondary data analyses with
the collection of primary data to further develop the evidence base for self-care
maintenance.
The results from the studies reported in this body of work indicate that many
patients with HF experience a wide range of potential vulnerabilities (ie: financial, place
of residence, health, age, functional status, developmental, ability to communicate
effectively, race, ethnicity and gender) in addition to a lack of social and cognitive
resources needed to successfully manage their health. Many patients also live with
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multiple chronic illnesses. In the context of competing priorities, patients may need
support to identify how to prioritize and make choices that optimize their health and
wellness.
The GMM analytic approach was a strength of the studies reported in both
Chapters III & IV. The use of GMM in Ch IV allowed for the identification of previously
unobserved biomarker patterns of change in an existing dataset of patients with HF.
GMM holds future potential as an analytic tool for helping to explain heterogeneity in
response to many self-care behaviors that are common among patients with HF. To date,
the GMM methodology has been used by other researchers to identify patterns of selfcare management and changes in QOL,79 profiles of self-care management versus
consulting behaviors,80 patterns of cognitive change in HF,81 and patterns of medication
adherence.82
One of the challenges of using GMM is that relative to other statistical
methodologies, it is relatively new (though it has been used for the past twenty years)83-85
and it takes time for methodological innovation to reach mainstream acceptance. The
feedback from a primarily clinical audience has been skepticism and concern about why
multiple biomarkers would be analyzed simultaneously or why these methods were
implemented instead of linear modeling. Just as there is a long lag between getting
research findings into clinical practice,86 the same is true for methodological innovation.
Despite that limitation, there are multiple opportunities to use GMM in the future
to identify specific archetypes or models of vulnerability in patients with HF. The first
step will be a detailed systematic review and meta-analyses of existing literature to
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statistically synthesize the effects of socio-demographic, environmental, clinical,
symptom and behavioral factors on poor HF outcomes, and generate robust theoreticoempirical archetypes of vulnerability.87 Archetypes of vulnerability can be characterized
in a multicenter bio-behavioral research database containing socio-demographic,
environmental, clinical, symptom, behavioral, QOL and clinical outcomes and tested in a
large national dataset.
Recommendations for Future Research
The focus of this research is consistent with the mission of the National Institute
of Nursing Research (NINR), which is to support research on the science of health,
focused on the promotion of health and improving quality of life by managing symptoms
and enhancing innovation in science and practice. NINR is focused on supporting
research that: 1) develops informatics-based solutions to promote health; 2) develops and
creatively applies new and existing knowledge to the implementation of health
information technology, including electronic health records; 3) expands knowledge and
application of health care technologies to facilitate decision support, self-management,
and access to health care.88
Further development of informatics-based solutions to promote self-care in
vulnerable populations, especially those with cognitive impairment, multiple chronic comorbidities and other vulnerabilities is critical. This issue was highlighted in MITI-HF,
where patient follow-up was a major challenge, primarily for people with cognitive
impairment. Being able to collect data with a simple mobile health application (app) 89,90
may have helped to decrease study attrition. Sending text-reminders or simple email
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prompts instead of calling someone on the telephone may have reduced that barrier to
engagement.
There is also scope for improving remote monitoring systems and being able to
more efficiently follow-up with vulnerable patients and improve patient-oriented
outcomes. The effectiveness of telemonitoring to improve clinical outcomes (readmission
for any reason or death from any cause within 180 days) for patients with HF was refuted
in a large trial reported by Chaudhry and colleagues;91 however, remote monitoring has
successfully been used to engage patients with HF in more intense self-care.92
Evangelista and colleagues found that after 3-months, patients who had transmitted their
weight and blood pressure through the remote monitoring system had improved
activation, self-care, and QOL.92
Likewise, in an effort to build better preventative services for Canadian patients
with HF, Nolan and colleagues are testing a Canadian e-platform to provide counseling to
facilitate adherence to self-care among patients with HF (ClinicalTrials.gov
NCT01864369).93 In vulnerable populations with multiple competing chronic illnesses,
the use of technology for follow-up monitoring and prompts is one avenue to promote
and advance research.
In future studies, I hope to utilize mobile apps for collecting data and smart
phones with biological sensors to capture real-time data from vulnerable patients with HF
who are also living with multiple chronic illnesses including cognitive impairment.
Despite broad access to smart phone technology, there is still a digital divide by age and
income.94 Overall, 58% of adult Americans have a smart phone and the prevalence is
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highest among African-Americans (59%) and Hispanics (61%). People over 65 years
have less access to a smart phone (19%) compared to 83% of people ages 18-29 years.
There are also discrepancies by income, 47% for people earning < $30,000/yr and 81%
for people earning >$75,000/yr.95 Future clinical research should harness the widespread
use of smart phone technology for patient follow-up and address the limitations of health
and technological literacy.
To stay at the cutting edge, I believe that it is imperative to develop interventions
that are responsive to patients needs in real-time. Future collaboration with computer
science and bio-engineers to develop sensors that can monitor hemodynamic congestion,
fatigue and dyspnea is critical. In addition, using electronic patient records for follow-up
on patient bio-markers and pairing follow-up data collection with clinical follow-up
appointments will make it more convenient for patients and less time-intensive for
research assistants. Collaboration with health economists for cost-effectiveness analyses
of interventions is also critical. For instance, the cost-effectiveness of a specific mobile
application designed to promote cardiac self-care among patients with heart disease in
Leon and Castille, Spain has been conducted and estimated to reduce costs and treatment
of cardiac diseases by one-third.96
Future research is needed on the decision making process and how to use tools to
measure successful decision-making and outcomes to either reinforce or provide
feedback for better decision-making. In the next era of genetics based personalized
medication regimes, there is also scope for personalized bio-behavioral interventions
because responses to interventions are often as disparate as responses to medications.
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Recommendations for Clinical Practice
Many clinicians believe that patients with HF who take care of themselves will
have better clinical and patient-oriented outcomes. While educating and promoting selfcare is assumed to be part of discharge teaching and disease management programs,97 it is
usually rushed and abbreviated compared to what patients need. Health providers seldom
have the time to adequately evaluate a patient’s self-care skills and barriers to
improvement. Results from this body of work support fostering self-care practices using
the principals of MI, particularly in the home where self-care practices can be
contextualized to the patient’s natural environment.
In addition, this body of work supports the use of targeting more vulnerable
groups of patients with nutritional support and counseling. For instance, younger patients,
those who are obese and have diabetes mellitus are high risk for consuming sodium levels
that are almost double the recommended values. Clinicians can use these data to support
more targeted interventions for patients with these clinical characteristics in order to
ensure that the patients understand the risks of high sodium consumption and how to
quantify how much sodium they are consuming.

159

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

Go AS, Mozaffarian D, Roger VL, et al. Heart Disease and Stroke Statistics-2014 Update: A Report From the American Heart Association. Circulation. Jan
21 2014;129(3):e28-e292.
Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. Feb 23
2010;121(7):e46-e215.
Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of
cardiovascular disease in the United States: a policy statement from the American
Heart Association. Circulation. Mar 1 2011;123(8):933-944.
Jencks S, Williams M, Coleman E. Rehospitalizations among Patients in the
Medicare Fee-for-Service Program. NEJM. 2009;360(14):1418-1428.
Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current
state and framework for future research. Circulation. Dec 20 2005;112(25):39583968.
Felker GM, Leimberger JD, Califf RM, et al. Risk stratification after
hospitalization for decompensated heart failure. J Card Fail. Dec 2004;10(6):460466.
Havranek EP, Masoudi FA, Rumsfeld JS, Steiner JF. A broader paradigm for
understanding and treating heart failure. J Card Fail. Apr 2003;9(2):147-152.
Riegel B, Dickson VV. A situation-specific theory of heart failure self-care. J
Cardiovasc Nurs. May-Jun 2008;23(3):190-196.
Riegel B, Carlson B, Moser DK, Sebern M, Hicks FD, Roland V. Psychometric
testing of the self-care of heart failure index. J Card Fail. Aug 2004;10(4):350360.
Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart
failure practice guideline. J Card Fail. Jun 2010;16(6):e1-194.
Bibbins-Domingo K. The institute of medicine report sodium intake in
populations: assessment of evidence: summary of primary findings and
implications for clinicians. JAMA Intern Med. Jan 2014;174(1):136-137.
Riegel B, Moser DK, Powell M, Rector TS, Havranek EP. Nonpharmacologic
care by heart failure experts. J Card Fail. Mar 2006;12(2):149-153.
Riegel B, Moser DK, Anker SD, et al. State of the science: promoting self-care in
persons with heart failure: a scientific statement from the American Heart
Association. Circulation. Sep 22 2009;120(12):1141-1163.
Riegel B, Lee CS, Dickson VV. Self care in patients with chronic heart failure.
Nat Rev Cardiol. Jul 19 2011;19(8):644-654.
Arcand J, Ivanov J, Sasson A, et al. A high-sodium diet is associated with acute
decompensated heart failure in ambulatory heart failure patients: a prospective
follow-up study. Am J Clin Nutr. Feb 2011;93(2):332-337.
Konerman MC, Hummel SL. Sodium restriction in heart failure: benefit or harm?
Curr Treat Options Cardiovasc Med. Feb 2014;16(2):286.

160

17.
18.
19.
20.
21.
22.

23.
24.

25.
26.
27.
28.
29.
30.
31.

Spaderna H, Zahn D, Pretsch J, et al. Dietary habits are related to outcomes in
patients with advanced heart failure awaiting heart transplantation. J Card Fail.
Apr 2013;19(4):240-250.
Son YJ, Lee Y, Song EK. Adherence to a sodium-restricted diet is associated with
lower symptom burden and longer cardiac event-free survival in patients with
heart failure. J Clin Nurs. Nov 2011;20(21-22):3029-3038.
Lennie TA, Song EK, Wu JR, et al. Three gram sodium intake is associated with
longer event-free survival only in patients with advanced heart failure. J Card
Fail. Apr 2011;17(4):325-330.
Song EK, Moser DK, Dunbar SB, Pressler SJ, Lennie TA. Dietary sodium
restriction below 2 g per day predicted shorter event-free survival in patients with
mild heart failure. Eur J Cardiovasc Nurs. Dec 23 2013.
Pfister R, Michels G, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Estimated
urinary sodium excretion and risk of heart failure in men and women in the EPICNorfolk study. Eur J Heart Fail. Jan 20 2014.
Paterna S, Fasullo S, Parrinello G, et al. Short-term effects of hypertonic saline
solution in acute heart failure and long-term effects of a moderate sodium
restriction in patients with compensated heart failure with New York Heart
Association class III (Class C) (SMAC-HF Study). Am J Med Sci. Jul
2011;342(1):27-37.
Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet
compared with low-sodium diet in compensated congestive heart failure: is
sodium an old enemy or a new friend? Clin Sci (Lond). Feb 2008;114(3):221-230.
Paterna S, Parrinello G, Cannizzaro S, et al. Medium term effects of different
dosage of diuretic, sodium, and fluid administration on neurohormonal and
clinical outcome in patients with recently compensated heart failure. Am J
Cardiol. Jan 1 2009;103(1):93-102.
Masterson Creber R, Topaz M, Lennie TA, Lee CS, Puzantian H, Riegel B.
Identifying predictors of high sodium excretion in patients with heart failure: A
mixed effect analysis of longitudinal data. Eur J Cardiovasc Nurs. Dec 23 2013.
Frediani JK, Reilly CM, Higgins M, Clark PC, Gary RA, Dunbar SB. Quality and
Adequacy of Dietary Intake in a Southern Urban Heart Failure Population. J
Cardiovasc Nurs. Mar 2013;28(2):119-128.
Dunbar SB, Clark PC, Deaton C, Smith AL, De AK, O'Brien MC. Family
education and support interventions in heart failure: a pilot study. Nurs Res. MayJun 2005;54(3):158-166.
US Department of Health and Human Services UDoA. Dietary guidelines for
Americans, 2010. US Department of Health and Human Services;2011.
Arcand J, Abdulaziz K, Bennett C, L'Abbe M R, Manuel DG. Developing a Webbased dietary sodium screening tool for personalized assessment and feedback.
Appl Physiol Nutr Metab. Mar 2014;39(3):413-414.
Gupta D, Georgiopoulou VV, Kalogeropoulos AP, et al. Dietary sodium intake in
heart failure. Circulation. 2012;126(4):479-485.
Arcand J, Floras JS, Azevedo E, Mak S, Newton GE, Allard JP. Evaluation of two
methods for sodium intake assessment in cardiac patients with and without heart
161

32.
33.

34.

35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.

46.

failure: the confounding effect of loop diuretics. American Journal of Clinical
Nutrition. 2010;93(3):535-541.
Damgaard M, Norsk P, Gustafsson F, et al. Hemodynamic and neuroendocrine
responses to changes in sodium intake in compensated heart failure. Am J Physiol
Regul Integr Comp Physiol. May 2006;290(5):R1294-1301.
Colin-Ramirez E, McAlister FA, Woo E, Wong N, Ezekowitz JA. Association
Between Self-reported Adherence to a Low-Sodium Diet and Dietary Habits
Related to Sodium Intake in Heart Failure Patients. J Cardiovasc Nurs. Mar 3
2014.
Day NE, McKeown N, Wong MY, Welch A, Bingham S. Epidemiological
assessment of diet: A comparison of a 7-day diary with a food frequency
questionnaire using urinary markers of nitrogen, potassium and sodium.
International Journal of Epidemiology. 2001;30(2):309-317.
Espeland MA, Kumanyika S, Wilson AC, et al. Statistical issues in analyzing 24hour dietary recall and 24-hour urine collection data for sodium and potassium
intakes. Am J Epidemiol. May 15 2001;153(10):996-1006.
Strom BL, Anderson CA, Ix JH. Sodium reduction in populations: insights from
the Institute of Medicine committee. Jama. Jul 3 2013;310(1):31-32.
Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement
from the American Heart Association Committee on exercise, rehabilitation, and
prevention. Circulation. Mar 4 2003;107(8):1210-1225.
O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training
in patients with chronic heart failure: HF-ACTION randomized controlled trial.
JAMA. Apr 8 2009;301(14):1439-1450.
Keteyian SJ, Leifer ES, Houston-Miller N, et al. Relation between volume of
exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol.
Nov 6 2012;60(19):1899-1905.
Downing J, Balady GJ. The role of exercise training in heart failure. J Am Coll
Cardiol. Aug 2 2011;58(6):561-569.
Kappagoda T, Amsterdam EA. Exercise and heart failure in the elderly. Heart
Fail Rev. Sep 2012;17(4-5):635-662.
Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of
trials in patients with chronic heart failure (ExTraMATCH). Bmj. Jan 24
2004;328(7433):189.
Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects
endothelial dysfunction and improves exercise capacity in patients with chronic
heart failure. Circulation. Dec 15 1998;98(24):2709-2715.
Jacques L, Jensen T S, Schafer J, Chin J, M I. Decision Memo for Cardiac
Rehabilitation (CR) Programs - Chronic Heart Failure (CAG-00437N). In:
Medicaid CfM, ed2014.
Keteyian SJ, Squires RW, Ades PA, Thomas RJ. Incorporating Patients With
Chronic Heart Failure Into Outpatient Cardiac Rehabilitation: Practical
Recommendations for Exercise and Self-care Counseling-A Clinical Review. J
Cardiopulm Rehabil Prev. Jul-Aug 2014;34(4):223-232.
Riegel B, Lee CS, Dickson VV, Carlson B. An update on the self-care of heart
failure index. J Cardiovasc Nurs. Nov-Dec 2009;24(6):485-497.
162

47.

48.
49.
50.
51.

52.
53.
54.
55.
56.
57.

58.
59.

60.

Baker DW, DeWalt DA, Schillinger D, et al. The Effect of Progressive,
Reinforcing Telephone Education and Counseling Versus Brief Educational
Intervention on Knowledge, Self-Care Behaviors and Heart Failure Symptoms.
Journal of Cardiac Failure. 10// 2011;17(10):789-796.
Dracup K, Moser DK, Pelter MM, et al. A Randomized Controlled Trial to
Improve Self-Care in Patients with Heart Failure Living in Rural Areas.
Circulation. May 9 2014.
Clark AP, McDougall G, Riegel B, et al. Health Status and Self-care Outcomes
After an Education-Support Intervention for People With Chronic Heart Failure. J
Cardiovasc Nurs. Jun 24 2014.
Albert NM, Buchsbaum R, Li J. Randomized study of the effect of video
education on heart failure healthcare utilization, symptoms, and self-care
behaviors. Patient Educ Couns. Dec 2007;69(1-3):129-139.
Balk AH, Davidse W, van Dommelen P, et al. Tele-guidance of chronic heart
failure patients enhances knowledge about the disease. A multi-centre,
randomised controlled study. European Journal of Heart Failure. November 1,
2008 2008;10(11):1136-1142.
Caldwell MA, Peters KJ, Dracup KA. A simplified education program improves
knowledge, self-care behavior, and disease severity in heart failure patients in
rural settings. Am Heart J. Nov 2005;150(5):983.
Boyde M, Turner C, Thompson DR, Stewart S. Educational interventions for
patients with heart failure: a systematic review of randomized controlled trials. J
Cardiovasc Nurs. Jul-Aug 2011;26(4):E27-35.
Dickson VV, Melkus GD, Katz S, et al. Building skill in heart failure self-care
among community dwelling older adults: Results of a pilot study. Patient Educ
Couns. May 5 2014.
Brodie DA, Inoue A. Motivational interviewing to promote physical activity for
people with chronic heart failure. J Adv Nurs. Jun 2005;50(5):518-527.
Tse MM, Vong SK, Tang SK. Motivational interviewing and exercise programme
for community-dwelling older persons with chronic pain: a randomised controlled
study. J Clin Nurs. Jul 2013;22(13-14):1843-1856.
Benzo R, Vickers K, Ernst D, Tucker S, McEvoy C, Lorig K. Development and
feasibility of a self-management intervention for chronic obstructive pulmonary
disease delivered with motivational interviewing strategies. J Cardiopulm Rehabil
Prev. Mar-Apr 2013;33(2):113-123.
Ang DC, Kaleth AS, Bigatti S, et al. Research to Encourage Exercise for
Fibromyalgia (REEF): use of motivational interviewing design and method.
Contemp Clin Trials. Jan 2011;32(1):59-68.
Mertens VC, Goossens ME, Verbunt JA, Koke AJ, Smeets RJ. Effects of nurseled motivational interviewing of patients with chronic musculoskeletal pain in
preparation of rehabilitation treatment (PREPARE) on societal participation,
attendance level, and cost-effectiveness: study protocol for a randomized
controlled trial. Trials. 2013;14:90.
Riegel B, Dickson VV, Hoke L, McMahon JP, Reis BF, Sayers S. A motivational
counseling approach to improving heart failure self-care: mechanisms of
effectiveness. J Cardiovasc Nurs. May-Jun 2006;21(3):232-241.
163

61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.

75.
76.

Shaya FT, Gbarayor CM, Huiwen Keri Y, Agyeman-Duah M, Saunders E. A
perspective on African American participation in clinical trials. Contemp Clin
Trials. Feb 2007;28(2):213-217.
Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014
update: a report from the American Heart Association. Circulation. Jan 21
2014;129(3):e28-e292.
Rucker-Whitaker C, Flynn KJ, Kravitz G, Eaton C, Calvin JE, Powell LH.
Understanding African-American participation in a behavioral intervention:
results from focus groups. Contemp Clin Trials. Jun 2006;27(3):274-286.
Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and
minorities in heart failure clinical trials. Archives of Internal Medicine.
2002;162(15):1682-1688.
Dickson VV, McCarthy MM, Howe A, Schipper J, Katz SM. Sociocultural
influences on heart failure self-care among an ethnic minority black population. J
Cardiovasc Nurs. Mar-Apr 2013;28(2):111-118.
Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener
to identify cognitive impairment among potential subjects for clinical research.
Med Care. Sep 2002;40(9):771-781.
Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive
Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am
Geriatr Soc. Apr 2005;53(4):695-699.
Hajduk AM, Lemon SC, McManus DD, et al. Cognitive impairment and self-care
in heart failure. Clinical epidemiology. 2013;5:407-416.
Harkness K, Heckman GA, Akhtar-Danesh N, Demers C, Gunn E, McKelvie RS.
Cognitive function and self-care management in older patients with heart failure.
Eur J Cardiovasc Nurs. Jun 2014;13(3):277-284.
Pressler SJ. Cognitive functioning and chronic heart failure: a review of the
literature (2002-July 2007). J Cardiovasc Nurs. May-Jun 2008;23(3):239-249.
Gure TR, Blaum CS, Giordani B, et al. Prevalence of cognitive impairment in
older adults with heart failure. J Am Geriatr Soc. Sep 2012;60(9):1724-1729.
Currie K, Rideout A, Lindsay G, Harkness K. The Association Between Mild
Cognitive Impairment and Self-care in Adults With Chronic Heart Failure: A
Systematic Review and Narrative Synthesis. J Cardiovasc Nurs. Jul 1 2014.
Konstam V, Lehmann I. Cognitive Impairment in Heart Failure. In: Mann DL, ed.
Heart Failure: A Companion to Braunwald's Heart Disease. Vol 2. St Louis,
Missouri: Elsevier Saunders; 2011.
Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J.
Cognitive dysfunction mediates the effects of poor physical fitness on decreased
functional independence in heart failure. Geriatrics & gerontology international.
Feb 18 2014.
Buck HG, Harkness K, Wion R, et al. Caregivers' contributions to heart failure
self-care: A systematic review. Eur J Cardiovasc Nurs. Jan 6 2014.
Cene CW, Haymore LB, Lin FC, et al. Family member accompaniment to routine
medical visits is associated with better self-care in heart failure patients. Chronic
Illn. Apr 16 2014.
164

77.

78.

79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.

91.

Vellone E, Chung ML, Cocchieri A, Rocco G, Alvaro R, Riegel B. Effects of selfcare on quality of life in adults with heart failure and their spousal caregivers:
testing dyadic dynamics using the actor-partner interdependence model. Journal
of family nursing. Feb 2014;20(1):120-141.
Skaperdas E, Tuepker A, Nicolaidis C, Robb JK, Kansagara D, Hickam DH.
Congestive heart failure self-management among US veterans: The role of
personal and professional advocates. Patient Educ Couns. Jun 2014;95(3):371377.
Lee CS, Mudd JO, Hiatt SO, Gelow JM, Chien C, Riegel B. Trajectories of heart
failure self-care management and changes in quality of life. Eur J Cardiovasc
Nurs. Jun 30 2014.
Lee CS, Gelow JM, Mudd JO, et al. Profiles of self-care management versus
consulting behaviors in adults with heart failure. Eur J Cardiovasc Nurs. Dec 31
2013.
Riegel B, Lee CS, Glaser D, Moelter ST. Patterns of Change in Cognitive
Function over Six Months in Adults with Chronic Heart Failure. Cardiol Res
Pract. 2012;2012:631075.
Riegel B, Lee CS, Ratcliffe SJ, et al. Predictors of objectively measured
medication nonadherence in adults with heart failure. Circ Heart Fail. Jul 1
2012;5(4):430-436.
Muthen B, Muthen LK. Integrating person-centered and variable-centered
analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin
Exp Res. Jun 2000;24(6):882-891.
Muthen B, Shedden K. Finite mixture modeling with mixture outcomes using the
EM algorithm. Biometrics. Jun 1999;55(2):463-469.
Muthén LKaM, B.O. Mplus User’s Guide. Sixth ed. Los Angeles, CA: Muthén &
Muthén; 1998-2010.
Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question:
understanding time lags in translational research. Journal of the Royal Society of
Medicine. Dec 2011;104(12):510-520.
Jurgens CY, Faulkner KM, Lee CS. Phenotypic profiling of cognitive impairment
risk among patients with heart failure: a literature review of the usefulness of
cardiac-related variables. Eur J Cardiovasc Nurs. Apr 2013;12(2):109-131.
National Institute of Nursing Research. Bringing Science to Life: NINR Strategic
Plan. In: National Institute of Health USDoHaHS, ed2011.
World Health Organization. mHealth: New horizons for health through mobile
technologies: Based on the findings of the second global survey on eHealth
(Global Observatory for eHealth Series). Vol 32011.
Martinez-Perez B, de la Torre-Diez I, Lopez-Coronado M, Sainz-de-Abajo B,
Robles M, Garcia-Gomez JM. Mobile clinical decision support systems and
applications: a literature and commercial review. Journal of medical systems. Jan
2014;38(1):4.
Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart
failure. N Engl J Med. Dec 9 2010;363(24):2301-2309.
165

92.
93.

94.
95.
96.

97.

Evangelista LS, Lee JA, Moore AA, et al. Examining the Effects of Remote
Monitoring Systems on Activation, Self-care, and Quality of Life in Older
Patients With Chronic Heart Failure. J Cardiovasc Nurs. Dec 19 2013.
Nolan RP, Payne AY, Ross H, et al. An Internet-Based Counseling Intervention
With Email Reminders that Promotes Self-Care in Adults With Chronic Heart
Failure: Randomized Controlled Trial Protocol. JMIR research protocols.
2014;3(1):e5.
Chang BL, Bakken S, Brown SS, et al. Bridging the digital divide: Reaching
vulnerable populations. Journal of the American Medical Informatics Association.
2004;11(6):448-457.
Pew Research Center. Mobile technology fact sheet. Pew Research Internet
Project 2014; http://www.pewinternet.org/fact-sheets/mobile-technology-factsheet/. Accessed June 24, 2014.
Cano Martin JA, Martinez-Perez B, de la Torre-Diez I, Lopez-Coronado M.
Economic Impact Assessment from the Use of a Mobile App for the Selfmanagement of Heart Diseases by Patients with Heart Failure in a Spanish
Region. Journal of medical systems. Sep 2014;38(9):96.
McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of
randomized trials of disease management programs in heart failure. The American
Journal of Medicine. Apr 1 2001;110(5):378-384.

166

